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Abstract

The Microvascular and Systemic Effects of Titanium Dioxide Nanoparticle Exposure: A
Physiological Perspective

Alaeddin B. Abukabda

Titanium dioxide nanoparticles (nano-TiO2) are one of the most widely used engineered
nanomaterials (ENM). Their ubiquitous inclusion warrants a more thorough
understanding of their toxicity, particularly in sensitive populations such as pregnant
women and the developing fetus.

The aim of the first study was to determine the most sensitive segments of the vasculature
to pulmonary ENM exposure. Macrovascular function was investigated in the thoracic
aorta, common femoral artery and 3rd order mesenteric arterioles using wire myography.
Microvascular function was assessed in 4th and 5th order mesenteric arterioles via
pressure myography. Nano-TiO2 exposure induced impairments in endotheliumdependent and -independent relaxation in the macrovasculature and dysfunction in the
microvasculature. Interestingly, this dysfunction was more robust in the microvessels.

The aims of the second study were: 1) to investigate the uterine microvascular
repercussions of pulmonary ENM exposure, 2) to identify the role played by innate
lymphoid cells in the inflammatory response to acute nano-TiO2 exposure. This study
proposes that group II innate lymphoid cells respond within 4 hours to damage-associated
molecular patterns from lung epithelial and innate immune cells in response to
intratracheal instillation of nano-TiO2. Furthermore, impairment of endotheliumdependent dilation of the uterine radial arterioles was identified 24 hours post-exposure.

Study 3 aimed to determine the effects of gestational nano-TiO2 exposure on the
maternal-fetal circulation. Based on previous research, we predicted that gestational
nano-TiO2 inhalation exposure would increase placental vascular resistance and impair
endothelium-dependent and -independent dilation of the umbilical microvasculature.
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I. Literature Review

With the introduction of novel man-made materials consisting of particles with at least one
dimension smaller less than 100 nm called engineered nanomaterials (ENM), unique health
hazards resulting from exposure to such materials has been identified [91]. Of the various possible
routes of entry into the body, the airway seems to be the easiest entry for ENM. After arrival into
the lungs, local lung injury can occur from nanoparticles [59]. In addition, effects can be seen
systemically in the cardiovascular system resulting from the effects of lung inflammation –
perhaps mediated by inflammatory cytokines [91]. Furthermore, inhaled ENM can be transported
to other organs by the cardiovascular system [62]. Because of intravascular transport, the
cardiovascular system can also become diseased with reduced ability to vasodilate as one of the
hallmarks of impaired function and disease risk [91]. However, it is not known if all parts of the
cardiovascular system are equally impaired. Since both the uterine and fetal circulation possess
unique adaptations [118], the fetal and placental circulation might be protected from the adverse
effects of ENM exposure on the maternal circulation. If not, then what is the outcome of ENM
exposure in the lung to the maternal-fetal exchange of nutrients?

1. Engineered Nanomaterials
A. Introduction. The demand for diverse materials with novel properties has led to the
advancement of the nanotechnology field. The unique physicochemical characteristics that
specific materials exhibit at the nanoscale make them highly desirable and versatile. Indeed, the
National Nanotechnology Initiative defined the term Nanotechnology as “the understanding and
control of matter at dimensions between approximately 1 and 100 nm, where unique phenomena
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enable novel applications” [85]. While it is apparent that nanotechnology holds tremendous
potential benefits, there are also significant risks to human health as the biological effects caused
by exposure are not adequately understood. For example, effects of particle exposure on human
health, particularly the cardiovascular system have been reported [106]. Several mechanisms
have been proposed to account for the increase in morbidity including; oxidative stress, systemic
inflammation, endothelial dysfunction, thrombosis and arrhythmia [88,142] following human
exposure.

B. Properties of Engineered Nanomaterials. The physicochemical properties of ENM are
fundamental determinants of their biodistribution and biokinetics [63,142]. The nanoscale size of
ENM results in a significantly greater surface area which leads to chemical reactivity that differs
from those of the corresponding bulk materials. Therefore, material characterization is necessary
to determine any potential toxic effects.

i) Size. The most fundamental ENM physical property determining pulmonary deposition,
extrapulmonary translocation, and cellular uptake is size [64,96]. ENM particles show a great
tendency to agglomerate into larger structures based on surface electrical potential and particle
diameter [73]. This agglomeration has a significant impact on the deposition pattern of ENM
within the respiratory tract [127].

The ability to enter the systemic circulation and the translocation pattern of ENM is correlated with
particle diameter [62]. ENM have extended circulating half-lives and are cleared less efficiently
by phagocytic cells than particles >100 nm. Ten nm gold nanoparticles (AuNP) translocated from
the blood to spleen, kidney, liver, testes, thymus, heart, lung, while larger particles (50 nm, 100
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nm, and 200 nm) were present predominantly in the liver and spleen [29]. ENM smaller than
serum albumin (40-50 kDa, approximate diameter 4-6 nm) are eliminated primarily through the
kidneys [10, 31]. Elimination occurs because of the selectivity of the glomerular filtration barrier
that restricts the passage of molecules according to size, shape and charge [13,14]. ENM within
the kidney may therefore avoid ultrafiltration, persist within the circulation, and translocate to other
organs, such as the liver and spleen.

Secondary destinations of ENM include the blood

conditioning organs with major homeostatic functions (liver, kidney, spleen). The accumulation
of ENM in these organs may simply be due to the significant portion of the cardiac output these
organs receive.

ii) Charge and Surface Chemistry. The surface properties of ENM are a direct product of their
size. The decrease in atomic radius occurring in nanoscale materials increases the energy gap
between electron transition states, resulting in an increased surface reactivity. This phenomenon,
known as quantum confinement, accounts for the difference in chemical reactivity between ENM
and bulk materials [138]. The surface properties of metals and metal oxides are influenced by
the presence of defects in their crystalline structures, adsorbed ions, and functional groups.
Carbonaceous ENM surface chemistry is determined primarily by the degree of bonding or
hybridization state of the individual carbon atoms [76]. The increased reactivity may favor the
interaction of ENM with biological molecules, subcellular components and the immune system.

Functional groups are specific moieties within molecules responsible for the chemical identity of
those molecules. The addition of these chemical groups (e.g. carboxylate, amines etc.) can
significantly modify the reactivity of ENM. Surface functionalization may influence biodistribution
[63], cellular uptake [23], and toxicity [74].
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The cell membrane possesses a net negative charge because of the presence of anionic residues
such as proteins, phospholipids and glycoproteins. The plasma membrane also contains discrete
microdomains of glycolipids and proteins known as lipid rafts. The localized distribution of these
negatively-charged biomolecules may selectively dictate the interaction with ENM based on
surface charge and chemical composition. Therefore, ENM with cationic chemical groups are
frequently used to promote cellular adsorption and uptake [24]. Mesoporous silica nanoparticles
(MSNP) coated with cationic polyethyleneimine (PEI) undergo greater cellular uptake than
unmodified MSNP [136]. Intravenously administered positively charged AuNP showed greater
adsorption to the cell membrane of circulating red blood cells than neutral or negatively charged
AuNP [49].

Surface chemistry may also determine the distribution of ENM to specific target organs and the
inflammatory response to ENM exposure. Intravenous administration of 2.8 nm AuNP coated
with negatively charged thioglycolic acid accumulated preferentially within the liver, while
positively charged AuNP showed higher circulating and kidney concentrations [49]. Ultrafine 60nm polystyrene-test particles (PSL) with a positive surface charge increased the tendency of
blood to clot compared to controls and carboxyl-coated PSL [87]. Charged (positive and negative)
nanoparticles elicit a more robust response by the immune system, undergo greater opsonization
and activate phagocytosis by cells of the mononuclear phagocytic system [25]. Furthermore,
multiwall carbon nanotubes (MWCNT) functionalized with PEI induced a greater NRLP3
inflammasome activation and IL-1β release in vitro by THP-1 cells than pristine and negatively
charged MWCNT [69]. In addition, activation of immunological pathways may result in the
systemic release of proinflammatory cytokines and oxidative stress, resulting in vascular
dysfunction [91].
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Historically, addition of functional groups has been employed to increase ENM circulation time
and maintain concentrations for therapeutic use. Amphiphilic polymer coatings are effective in
reducing first-pass metabolism by the liver [54]. Increasing surface hydrophobicity by coating
liposomes with erythrocytic sialic acid moieties reduced opsonization and clearance by phagocytic
cells [5]. Coating nanoparticles with polysaccharides such as dextran [86] and polyethylene glycol
[59] increased plasma half-life by decreasing activation of innate immunity.

The osmolarity, pH, and charge of specific intracellular and extracellular compartments can also
impact ENM surface chemistry [51]. When suspended in a liquid phase, ENM form a colloidal
system. The stability of this system and the interaction with cellular components can be assessed
by measuring the zeta potential of ENM [141]. The zeta potential predicts the electro kinetic
behavior of particles in solution and is a measure of the electrostatic attraction or repulsion
between ENM particles [34]. Metal oxides show an increased agglomeration in pH environments
approaching their isoelectric point [107]. The increase in particle size caused by agglomeration
may decrease renal clearance and increase ENM plasma half-life. This could increase the
likelihood of deposition within the vascular wall and compromise cardiovascular health.

When ENM enter physiological compartments, a complex mixture of proteins and biomolecules
may bind non-specifically to their surface. The composition of this adsorbed coat, also known as
protein corona, is influenced by ENM surface chemistry [4,102]. The dynamics of this interaction
are defined by ENM physicochemical properties [111]. The acquisition of a distinct protein corona
may influence the ‘biological identity’, cellular uptake, and the immunogenicity of ENM [33,129].
In a recent study, the adsorption of serum proteins to AuNP was inversely dependent on size
[129]. Plasma IgG showed a higher affinity for 100 nm and 50 nm plain PSL nanoparticles, and
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little binding to carboxyl- and amine- modified 50 nm PSL nanoparticles [74]. The formation of a
protein corona has been shown to increase macrophage phagocytic activity [129] and elicit a
more pronounced innate immune response. Further, it may also enhance ENM biocompatibility
(38), and regulate their impact on the cardiovascular system.

iii) Shape. Recent studies have highlighted the importance of ENM morphology in the interaction
with biological systems. ENM with a high length to diameter ratio or aspect ratio (nanorods,
nanobelts, nanowires and nanotubes) may pierce cellular membranes and disrupt anatomical
barriers. ENM with high curvature angles resist uptake by phagocytic cells, particularly
macrophages [20]. MWCNT with a low aspect ratio (220 nm length and 25 nm diameter)
administered subcutaneously in rats persisted within the cytosol of macrophages for more than 4
weeks. High aspect ratio MWCNT (825 nm length and 25 nm diameter) were not phagocytized
and triggered a robust inflammatory response [109].

Ellipsoid particles are more readily

phagocytized by cells of the immune system than spherical particles [112]. Gold nanorods of
greater aspect ratio are not only internalized slower than shorter ones but are more toxic to human
HeCaT keratinocytes [130]. The inability to efficiently clear ENM by the immune system may result
in frustrated phagocytosis and pro-fibrotic cellular responses [130] including the release of
proinflammatory chemokines that may lead to peripheral vascular consequences.

ENM aspect ratio must be considered when determining potential vascular effects. ENM with
high aspect ratios (nanotubes, nanobelts and nanowires) are more likely to interrupt laminar flow,
deposit in the vascular wall and damage endothelial or vascular smooth muscle cells. ENM may
also interact with endothelial cells under conditions of turbulent flow or in bifurcations. High aspect
ratio fibers may cause occlusion of microvessels and promote thrombus formation.
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iii) Chemical composition. Chemical composition remains the primary factor for risk from ENM
[17]. Therefore, the primary focus of this review will be on the most common nanomaterials
subdivided according to chemical composition: metals, metal oxides, and carbonaceous
nanomaterials.

iv) Routes of entry. The exposure route greatly influences the overall toxicity and the amount of
ENM deposition, translocation and interaction with tissues, cells or specific intracellular
components. Historically, considering the ease with which ENM can be aerosolized and inhaled,
the most frequently studied exposure route has been the pulmonary route. Recent developments
in ENM-based therapies and their ubiquitous presence, other routes such as ocular, gastric,
dermal and injection are becoming ever more important and should not be overlooked.

a) Inhalation. Inhalation is the most common and the most investigated exposure route.
Experimentally, three exposure methods for lung deposition of particulate matter are commonly
employed: inhalation, intratracheal instillation and oropharyngeal aspiration. Inhalation creates an
artificial atmosphere saturated with particulate matter. Particle deposition is then driven by
physiological processes and thermodynamic phenomena. While generally considered as the
“golden standard” for pulmonary exposure studies, whole-body inhalation requires significant
amounts of material, trained personnel and costly equipment. The two major systems used for
inhalation exposures involve whole body inhalation and head/nose-only. Whole body inhalation
requires large amounts of bulk material and may result in dermal or oral exposure but has the
advantage of allowing the simultaneous exposure of multiple animals for extended periods of
time. Nose-only systems limit exposure via other routes by employing a restraint inserted into a
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plenum. Even though this technique is more efficient and requires less bulk material, the restraints
may cause significant stress to the animals [120,133].

b) Instillation. Instillation involves lightly anesthetizing the animal and administering particles
suspended in a medium directly into the lungs via a ball tipped needle. Instillation is simpler than
inhalation (even though some training is required to avoid accidentally gavaging the animals),
less expensive and provides a consistent lung deposition. However, particle instillation is an
artificial mode of delivery of particulate matter to the lungs. Rats and mice are obligate nose
breathers and intratracheal instillation bypasses the nose and upper airways. Therefore, the lung
deposition may be substantially different compared to whole-body inhalation. However, it has
been shown that even though the dose rate between inhalation and instillation may be different,
the pulmonary distribution and biological effects are similar if the delivered dose is equivalent [6].

2. Nanoparticle inhalation and lung injury,
A. Size and location
The aerodynamic behavior and therefore deposition of particulate matter in the different regions
of the pulmonary tract is highly dependent on size [62]. Due to size, ENM deposit throughout the
lungs by diffusion and their deposition in the distal or alveolar region increases significantly as
particle size decreases. The converse is true for larger particles that deposit in the lungs by means
of sedimentation and impaction. Generally, larger particles and agglomerates tend to deposit in
the upper, tracheobronchial regions; while ENM tend to deposit throughout the entire lung,
including the alveolar region.
B. Cell injury and inflammation
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Inflammation is a well-established consequence of pulmonary ENM exposure. For example, 90day exposure to MWCNT resulted in a concentration-dependent multifocal granulomatous
inflammation, diffuse histiocytic and neutrophilic inflammation and intra-alveolar lipoproteinosis,
indicative of lung damage oxidative stress [109]. Furthermore, rat intratracheal instillation of zinc
oxide nanoparticles (ZnO-NP) induced eosinophilia, proliferation of airway epithelial cells and
goblet hyperplasia 24 hours post-exposure [135]. Short-term inhalation exposure (2.5 and 12.5
mg/m3 - 6 h/day exposure for 5 days) of coated ZnO-NP increased bronchoalveolar lavage fluid
inflammatory parameters, resulted in a reversible granulocyte infiltration in the lungs, increased
alveolar macrophages and induced a mild to moderate multifocal necrosis of the olfactory
epithelium [135]. Sub-chronic inhalation exposure (5 days) of rats to silver nanoparticles (Ag-NP)
induced chronic alveolar inflammation and small granulomatous pulmonary lesions [44]. Ceriumdioxide nanoparticles (CeO2-NP) have also been shown to induce pulmonary inflammatory
reactions and toxicity [78]. Four-day (2 h/day) inhalation of uncoated CeO2-NP with a primary
particle size of 90 nm induced lung injury and inflammation with increased neutrophil infiltration
and elevated levels of the pro-inflammatory cytokines IL-1α, monocyte chemotactic protein 1
(MCP-1), macrophage colony stimulating factor (MCSF) in lung tissue. Mild but persistent diffuse
histiocytosis was also reported. Lastly, the inflammatory effects of pulmonary exposure to titanium
dioxide nanoparticles (nano-TiO2) have also been extensively investigated [89]. Two-year
inhalation exposure (6 h/day, 5 days/week) of rats to nano-TiO2 induced pulmonary induced
increased levels of pro-inflammatory cytokines in the bronchoalveolar lavage fluid,
bronchioalveolar adenomas and cystic keratinizing squamous cell carcinomas in a dosedependent manner [89]. The complex effects of pulmonary ENM exposure on both the innate and
adaptive branches of the immune system require further studies on the role of other immune
effector cells (e.g., innate lymphoid cells, lymphocytes etc.).
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3. ENM exposure and vascular dysfunction
The cardiovascular system is composed of a central pump (the heart) and a closed system of
conduits responsible for transport and distribution of nutrients and waste removal. In attempting
to predict the effects of ENM exposure on this system several factors must be considered. First,
the distribution of ENM within each vascular segment as a result of direct introduction of ENM in
the vascular system or indirectly through other routes depends upon the physicochemical
characteristics of the nanomaterial and the dominant physical forces. Second, the severity of the
effects of ENM deposition are dictated by the function of each vascular segment (Figure 1). The
entity and magnitude of the dominant physical forces in each vascular segment are at the root of
the structural heterogeneity of the circulatory system. These forces may account for the
distribution and impact of ENM within each vascular segment [119].

A) Microcirculation. The microcirculation is defined as all the vascular tissue within a given organ,
which includes arterioles, the capillary network, venules and part of the lymphatic system [104].
The essential function of the microcirculation is the maintenance of an ideal environment for the
controlled exchange of nutrients and metabolic waste. For this exchange to occur efficiently, a
high surface area and resistance to flow are necessary. Arterioles are involved in the regulation
of blood flow and pressure. The arteriolar and venular segments of the microcirculation are under
a state of continuous basal contraction known as vascular tone. This baseline tension is mediated
by vascular smooth muscle cells.

Adjacent to the vascular smooth muscle cells are the

endothelial cells, which detect changes in the intraluminal environment. Coordinated interaction
between vascular smooth muscle cells and endothelial cells allows for alterations in vascular tone
in response to localized environmental changes [9].

10

The local characteristics specific to the microcirculation may lead to a diffused distribution of ENM
throughout tissues. A greater tendency towards laminar flow is seen at a threshold vessel
diameter of ∼ 300 µm [119]. Along with a decreased blood flow and pressure, favors ENM to
settle within the microvascular compartment. In conditions of laminar flow, the Segre - Silberberg
effect is used to describe parabolic flow pattern of colloidal suspensions. Erythrocytes travelling
at higher flow velocities remain in the flow centerline, while smaller particles (including ENM) and
non-cellular elements are forced laterally towards the vascular wall [103].

Blood consists of a solid phase (formed elements) suspended in a liquid phase (plasma). This
biphasic composition causes blood to behave as a non-Newtonian fluid in the microvasculature.
A Newtonian fluid characteristically maintains constant viscosity with increasing shear rate. Blood
exhibits shear thinning (or Fahraeus effect) in microvessels and hematocrit (or volume percentage
of erythrocytes) gradually decreases towards the capillaries. The decrease in hematocrit seen
as capillaries are approached is a result of the branching vascular architecture and increased
resistance. At bifurcations the distribution of erythrocytes between two daughter branches is often
unequal and may result in one branch receiving a lower proportion of cells relative to the other
daughter branch [105]. ENM concentrations may therefore increase with decreasing vessel
diameter.

The venous compartment is responsible for returning blood from the systemic organs to the heart
and for storage of blood due to its high capacitance. Since about 65% of blood volume is localized
in veins, a significant proportion of ENM may be found here [9].
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B) Examples of vascular ENM toxicity.
i) Metallic ENM
a) Gold Nanoparticles. AuNP have been historically used in medicine as therapeutic agents and
are now also utilized in biological imaging and as drug delivery systems. Their bioinert character
coupled with a high biocompatibility has fostered significant interest in their implementation as
both a therapeutic and diagnostic (theranostic) agent. Their optical properties, characterized by
enhanced absorption and scattering at specific electromagnetic wavelengths, have contributed to
the application of AuNP for cancer imaging [80].

In a porcine model of the blood brain barrier (BBB), brain microvascular endothelial cells treated
with 3 and 5 nm AuNP displayed an increase in vascular permeability but no change in systemic
levels of the proinflammatory cytokines TNF – α and IL- 1β [123]. Wistar – Kyoto rats infused
with different sizes (10 nm – 100 nm) of AuNP presented hepatic leukocytic infiltration, and
disruption of the central vein intima in a size-dependent manner [2]. Damage to the venous wall
could potentially lead to impaired capacitance as well as a decreased venous return.

Gold nanorods functionalized with polyelectrolytes induced cytotoxicity of aortic vascular
endothelium and impaired endothelium-dependent relaxation of aortic rings [3]. In a separate
study, 5 nm AuNP were shown to hyperpolarize aortic vascular smooth muscle due to activation
of BKCa potassium channels and influx of potassium ions, leading to vascular relaxation in an
endothelium-independent manner [116].
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b) Silver Nanoparticles. Perhaps the most utilized metallic nanoparticle, silver nanoparticles
(AgNP) are an almost ubiquitous component in the health industry and food storage. The strongantibacterial properties of AgNP have led to their wide application from home appliances to water
treatment [12]. Silver ions released by AgNP collapse the proton motive force in Vibrio cholera,
resulting in cell death [32].

Silver ions depress the activity of bacterial respiratory chain

dehydrogenases and damage bacterial cell membrane structural integrity [70]. Cotton fibers
containing AgNP display potent antibacterial activity against major human pathogens, including
Staphylococcus aureus [70]. These antibacterial capabilities may have inadvertently fostered the
notion that AgNP could affect mammalian systems in a similar manner.

AgNP also display unique optical properties that arise from the oscillations of conduction electrons
at an excitation wavelength of around 385 nm [38]. AgNP possess enhanced absorption and
scattering intensities compared to other nanoparticles. The wavelength of the emitted light is
dependent on both particle size and surface refractive index. These properties as well as the
inherent catalytic property of AgNP allow them to be potentially useful as nanoscale sensors and
optical data storage devices [61].

Like AuNP, AgNP exposure has been associated with antiangiogenic effects, suggesting a shared
mechanism of vascular toxicity by metal nanoparticles. Vascular endothelial growth factor
(VEGF)-induced cell proliferation, migration as well as capillary formation in bovine retinal
endothelial cells were markedly reduced following exposure via inhibition of the PI3K/Akt pathway
[46].
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In an in vitro BBB model, isolated rat brain microvascular endothelial cells treated with increasing
AgNP sizes (25, 40 and 80 nm) showed an increased cytotoxicity and proinflammatory response
in both a size and time (4 and 8 hours) dependent manner [124]. Larger AgNP were associated
with a less severe inflammatory response and microvascular cytotoxicity. The time-dependence
of the cytotoxic effects of AgNP was also visible in human microvascular endothelial cells and
endothelial-colony forming cells. At high concentrations, AgNP can damage cell membranes,
initiate DNA damage and stimulate the formation of free radicals. Interestingly, at sublethal
concentrations, microvascular cells remained viable but showed a significant impairment in
proliferation [19]. In isolated aortic rings, AgNP exposure resulted in a dose-dependent inhibition
of nitric oxide-mediated relaxation, while coronary vessel dilation was unimpaired [43]. AgNP
were preferentially internalized by human umbilical vein endothelial cells, resulting in the
formation of reactive oxygen species (ROS), cytoskeletal actin rearrangement, and disruption of
intercellular endothelial integrity. Increased vascular permeability was observed in Balb/c mice
exposed intravenously to AgNP leading to the systemic release of AgNP and peripheral
inflammation in the liver, lungs and kidneys [44]. Endothelial cell injury, dysfunction and oxidative
stress induced by exposure to AgNP occurs due to activation of the inflammatory IKK/NF-κB
pathways [114].

c) Copper. Copper nanoparticles (CuNP) have also been successfully used as antimicrobial
agents, in textiles, plastics and as additives for coatings. The antimicrobial activity of CuNP has
been associated with ROS generation, nucleic acid damage, lipid and protein oxidation [21]. The
high thermal conductivity and catalytic activity of CuNP make them efficient as sintering additives
and catalysts for chemical reactions such as in the synthesis of methanol and glycol.
Notwithstanding these industrial uses, CuNP are classified as a class 3 (moderately toxic) agent
with cytotoxic and proinflammatory effects being reported in vitro [123]. The direct toxic effects
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of CuNP on the different components of the cardiovascular system are less well understood and
additional research is warranted. Porcine brain microvessel endothelial cells treated with 15 µg/ml
CuNP of different sizes (40 and 60 nm) increased cellular permeability in a size-dependent
manner with a greater cytotoxic effect visible with smaller particles. The increased permeability
has been linked with increased levels of the proinflammatory cytokines TNF-α, IL-1β, and
prostaglandins (86). CuNP have also been linked with ROS generation and inflammation in
mouse pulmonary epithelial cells and human cardiac microvascular endothelial cells [121]. In a
chick embryo model, CuNP exposure resulted in marked proangiogenic and proliferative effect
via upregulation of VEGF and other angiogenic factors [83,84].

It is noteworthy that modulation of VEGF signaling is a recurring theme in the antiangiogenic
effects of metallic ENM. This effect may occur due to inhibition of phosphorylation of associated
downstream effector molecules including Src [56] and Akt [97] leading to increased apoptosis of
endothelial cells [40], impaired hematopoietic cell development, survival, differentiation, and
migration [66,79], aberrant vasculogenesis and heart development in prenatally exposed subjects
[80].

ii) Metal Oxides
a) Titanium Dioxide Nanoparticles. Nano-TiO2 is among the most widely used nanomaterials. Its
pervasive use has caused nano-TiO2 to be associated with systemic effects and to be classified
as a potential occupational carcinogen to humans [90]. Its ability to function as a high-energy
electron donor following treatment with UV light makes nano-TiO2 a versatile ENM with
applications in consumer products such as topical sunscreens and cosmetics and industrial
components including paints [115].
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Pulmonary nano-TiO2 exposure has been associated with systemic inflammation in vivo [91, 132].
Leukocyte activation, the release of proinflammatory mediators, oxidative stress and DNA
damage [27] leading to endothelium-dependent dysfunction. In isolated subepicardial arterioles
of rats exposed to nano-TiO2, (primary particle diameter ∼ 21 nm) a significant impairment in
endothelium-dependent vasodilation was noted [67]. Similar findings were reported in other
vascular beds including the uterus [117] and the spinotrapezius muscle [92]. This endotheliumdependent microvascular dysfunction has been linked with a reduced nitric oxide bioavailability
triggered by the generation of ROS following exposure or via the initiation of inflammatory
mechanisms in the lung [68,93]. Similarly, acute (24 hour) exposure to nano-TiO2 reduced
microvascular nitric oxide bioavailability and altered cyclooxygenase-mediated vasoreactivity. An
increased sympathetic tone was seen in exposed rats, indicating an enhanced adrenergic
sensitivity via upregulation of α-adrenergic receptor density or increased release of
neurotransmitters such as norepinephrine and neuropeptide Y at neurovascular junctions [58].
Thus, an augmented sympathetic tone could have a significant impact on the microcirculation,
particularly capacitance vessels, which show a more pronounced response to α-adrenergic
stimulation [1]. The increase in venous tone may result in greater capillary filtration or reduced
reabsorption, reduced plasma volume, and increased hematocrit.

The mechanisms underlying the effects of nano-TiO2 exposure on the vasculature are well
documented. Nano-TiO2 exposure may lead to an impaired vascular function via ROS which
react with nitric oxide produced by endothelial cells, decreasing its bioavailability [93]. In addition,
Pulmonary exposure to nano-TiO2 causes the systemic release of proinflammatory cytokines and
increased leukocyte activation.

Lastly, an increase in sympathetic activation and altered

cyclooxygenase signaling caused by nano-TiO2 have also been shown to affect vascular reactivity

16

[60]. Moreover, inhalation of nano-TiO2 also increases sympathetic tone via activation of the
transient receptor potential channel in pulmonary C-fiber sensory neurons. The increased C-fiber
activity augments neuronal function in the nodose ganglion and consequently affects autonomic
regulation by the medullary cardiovascular regulatory center [57].

b) Cerium dioxide Nanoparticles. The catalytic properties of CeO2-NP have made them excellent
diesel fuel additive [18] to increase combustion efficiency. Also, the capability of CeO2-NP to shift
between two valence states (Ce3+ and Ce4+) by reacting with highly reactive free radicals such as
superoxide make it useful as an antioxidant agent [26].

Systemic exposure to CeO2-NP results in a time-dependent increase in oxidative stress [138,139].
The long-term persistence and adverse effects associated with CeO2-NP exposure have raised
significant concerns about its therapeutic potential as an antioxidant. Its impact on cardiovascular
function is poorly understood but recent studies with human aortic endothelial cells exposed
acutely (4 hours) to CeO2-NP at different concentrations (0.001 – 50 µg/ml) revealed a modest
elevation of inflammatory markers such as intercellular adhesion molecule 1 (ICAM-1), MCP-1
and IL-8 [42]. While this study shows a modest effect on the macrocirculation, previous work
conducted by our lab has shown that pulmonary exposure to CeO2-NP impairs coronary and
microvascular endothelium-dependent and independent dilation in a dose- and route-dependent
manner [77,78]. The microvascular dysfunction seen in the microcirculation was linked to ROS
production, decreased nitric oxide production and an elevated level of inflammatory cytokines
[77].

17

Like nano-TiO2, exposure to CeO2-NP may trigger ROS generation, via nitric oxide synthase
uncoupling and mitochondrial damage, thus affecting endothelium-derived nitric oxide signaling
and vascular smooth muscle function. An inflammatory response to CeO2-NP exposure has been
suggested to play a role in these vascular effects [77].

c) Iron Oxide Nanoparticles. In recent years, increasing investigations with various types of iron
oxide nanoparticles (FeO-NP) (mostly maghemite, ү-FeeO3, and magnetite, FeeO4) have explored
the potential biomedical applications. Based on their thermal and electrical conductivity and
magnetic properties, FeO-NP have found applications as targeted drug delivery systems, in
magnetic resonance imaging, and as a contrasting agent [45].

Despite these clinical applications, the use of FeO-NP has come under scrutiny due to the
pronounced cytotoxic effects induced by exposure. For example, occupational exposures of FeONP induce severe complications such as siderosis and hemochromatosis due to iron overload
[15,52]. Similarly, cytotoxic effects to vascular endothelium due to the catalytic generation of ROS
through Fenton chemistry FeO-NP [16,142] have been reported. The generation of free radicals
was measured in human umbilical endothelial cells treated with dextran stabilized FeO-NP in vitro
[134]. In addition, particle phagocytosis by monocytes resulted in significant oxidative stress and
severe endothelial toxicity [142]. Furthermore, intravenous injection of FeO-NP (0.4, 2 and 10
µg/kg) in mice initiated significant prothrombotic effects in pial arterioles and venules as early as
1-hour post-exposure, along with increased cardiac levels of markers of oxidative stress, including
lipid peroxidation, ROS levels and increased superoxide dismutase activity [86].
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d) Zinc Oxide Nanoparticles. ZnO-NP have been historically used as an anti-bacterial and in
cosmetics such as sunscreen lotions due to their UV-blocking ability. However, severe systemic
and cytotoxic effects have been linked with ZnO-NP exposure. DNA fragmentation, mitochondrial
damage and toxicity through ROS generation have been reported in diverse in vitro studies
[112,121] and in vivo exposure models [58].

In vitro ZnO-NP exposure caused significant cytotoxic effects on human cardiac microvascular
endothelial cells and elicited a strong inflammatory response associated with the dissolution of
ZnO-NP and the release of highly reactive ionic groups [135]. ZnO-NP internalized by human
aortic endothelial cells showed pronounced inflammation and cell death [41, 101, 125].

ii) Carbonaceous Nanomaterials
a) Single Walled Carbon Nanotubes. Single-walled carbon nanotubes (SWCNT) are ENM which
can be visualized as a single graphene sheet is rolled up to form a cylinder [28,90]. Biomedical
applications include utilization as anti-microbial agents and drug-delivery systems.

Inhaled

SWCNT deposits efficiently in the lungs and induces inflammatory changes including the release
of thrombogenic factors, particularly plasminogen activator inhibitor 1 (PAI-1) [37]. PAI-1 is a
serine protease inhibitor responsible for the inhibition of plasminogen activation, intravascular
fibrinolysis, cell-associated proteolysis and blood clot dissolution [26]. Under normal conditions,
PAI-1 is present in plasma in very low concentrations (5-20 ng/ml) and is secreted primarily by
liver cells, smooth muscle cells, adipocytes and platelets. However, in diseased conditions such
as chronic inflammation, PAI-1 is also secreted by activated leukocytes and endothelial cells upon
stimulation by inflammatory cytokines (for example TGF-β) [75]. Increased circulating PAI-1
levels have been associated with atherosclerosis and coronary artery disease [11].
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Effects on aortic rings have been previously noted [47], with SWCNT exposure stimulating
endothelial nitric oxide-independent mechanisms of vasorelaxation. Conversely, acetylcholinetriggered vasorelaxation was unaltered in ApoE-/- mice intratracheally instilled with SWCNT and
no inflammatory response was detected in isolated aortic segments [127]. Similar studies have
reported contrasting evidence with increased cytotoxicity, and disruption of endothelial cell
cytoskeletal integrity in vitro [128]. Several in vitro studies have also indicated antiangiogenic
effects, decreased nitric oxide production and ROS generation in dermal microvascular
endothelial cells [7] and umbilical vein endothelial cells [108].

b) Multi Walled Carbon Nanotubes. MWCNT consist of multiple concentric graphene sheets rolled
up to form a cylinder. An ever-increasing number of MWCNT are being used as drug delivery
systems, tracers, contrast agents as well scaffolding for tissue [30].

The systemic effects of MWCNT exposure raise major concerns over their widespread use.
Pulmonary exposure to MWCNT has been associated with inflammatory responses like those
triggered by asbestos [98]. Furthermore, MWCNT have been shown to stimulate the production
of cytokines and induce cytotoxicity [48]. In the macrocirculation, human aortic endothelial cells
exposed in vitro to MWCNT for 24 hours at concentrations of 1.5-4.5 µg/ml showed significant
actin filament and cadherin disruption and cytotoxicity [128]. Pulmonary instillation of SpragueDawley rats with increasing doses (1, 10 or 100 µg) of MWCNT promoted cardiac injury by
increasing premature ventricular contractions and myocardial infarctions in an ischemia /
reperfusion model. Higher levels of endothelin-1, thromboxane, cyclooxygenase and Rho-kinase
correlated with increased coronary constriction and reduced blood flow [122].
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Rho-kinase

signaling was also increased in pregnant Sprague-Dawley rates exposed to MWCNT on
gestational days 17-19, resulting in an increased contractile response in uterine artery segments,
mesenteric artery but not in the umbilical vein [122].

In a time-course study performed by our research program [119], MWCNT inhalation resulted in
significant pulmonary infiltration of inflammatory cells and systemic translocation of ENM 24 hours
post-inhalation. Coronary arteriolar function assessed 24 – 168 hours post-exposure indicated
an impairment of endothelium dependent dilation within 24 hours. After 168 hours, this condition
showed modest improvement but was still partially present.

4. Human health effects of ENM
An increasing body of research in both humans and experimental animal models has raised
concerns regarding the potential biological effects of ENM in humans [111]. While these studies
built from knowledge gained from other occupational and environmental exposures (e.g., ambient
particulate matter, asbestos, silica), the potential long-term effects such as fibrosis and cancer
have not been observed because of latency. In humans, initial cross-sectional epidemiological
studies have indicated early response effects due to ENM exposure [111]. Indeed, ENM have
been shown to elicit oxidative stress responses in workers involved in the production or use of
ENM in Taiwan [71,72]. Exposure to carbon nanotubes and nanofibers was associated with
inflammation, fibrosis, oxidative stress, and cardiovascular biomarkers. In that same cohort,
exposure was associated with respiratory allergies and altered resting heart rate but no other
clinical measures [39]. Markers of lipid, nucleic acid and protein oxidation were found to be
increased in the exhaled breath condensate of workers exposed to FeO-NP [100]. On a similar
note, workers exposed to carbon black and MWCNT had increased blood levels of fibrinogen and
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pro-inflammatory mediators and increased or altered sputum or exhaled breath condensate levels
of oxidative stress, proinflammatory and profibrotic markers of workers exposed to MWCNT
[72,99,101].

Occupational exposure to titanium dioxide, evaluating workers from 1935-1985, was not
associated with an increased risk of developing lung cancer and other fatal respiratory diseases
including pulmonary fibrosis [22]. More recently, occupational exposures to TiO2, which has a
substantial nano-sized fraction, were associated with increased levels of leukotrienes in the
exhaled breath condensate [101].

Overall, initial epidemiological studies have indicated effects of exposure to ENM primarily related
to inflammation and oxidative stress. To date, and primarily the result of latency, cancer and
chronic pulmonary effects such as fibrosis have not been observed.

4. ENM exposure and reproductive and developmental outcomes
A. Introduction. In recent years, the reproductive and developmental consequences of ENM
exposure have become recognized as an important part of the field of toxicology. Several studies
have shown the potential of ENM to impact reproduction and fetal development [53]. The
mechanisms involved are unclear but may involve inflammation [53], oxidative stress [117],
endocrine disruption, mitochondrial dysfunction, epigenomic changes and impairments of the
maternal-fetal circulation [121]. Indeed, maternal nano-TiO2 exposure resulted in altered
expression of genes associated with brain development, cell death, response to oxidative stress,
and mitochondria in the brain during the prenatal period [35]. Similarly, pulmonary nano-TiO2
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exposure was shown to induce potentially deleterious epigenomic changes, cognitive and
vascular impairments in gestationally exposed progeny [36]. Gestational nano-TiO2 exposure
causes a reduction in litter and pup size as well as pup number. Exposure of pregnant Slc mice
to 137 mg/kg of fullerenes on GD 10 resulted in the death of all the embryos, while 50 mg/kg
induced head and tail abnormalities in 50 % of the fetuses [35]. Female mice administered
functionalized SWCNT at 10 or 100 mg/kg on GD 9 by oral gavage increased the incidence of
fetal resorptions, gross defects and skeletal abnormalities [55]. Injection of pregnant mice with
SWCNT on GD 5.5 at 0.01–30 mg/mouse increased the incidence of miscarriage and
malformations such as deformities in the abdominal wall and head and limb hypoplasia. The
placentas from the malformed fetuses were small and vascular damage was observed and
oxidative stress was increased in the malformed fetuses and their placentas [35]. Adverse effects
on spermatogenesis, histopathological changes in the testes and decreased testosterone levels
have also been reported in mice following gestational exposure to carbon black [53].

The “Barker Hypothesis” proposes that fetal development within a hostile gestational environment
may predispose the offspring to future health conditions and that adverse in utero and postnatal
environmental influences directly increase disease susceptibility [121]. Given the critical role the
uterine microcirculation plays in the regulation and distribution of blood flow to the developing
fetus, any impairment in the function of this vascular bed may affect the survival of a pregnancy.
Precise regulation of blood flow, especially within an environment characterized by profound
remodeling and growth, is crucial for both maternal and fetal health.

B, The Uterine Circulation.
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i) Anatomy. In humans, the uterus is supplied bidirectionally by means of a dual arterial
anastomotic system with one end (ovarian artery) deriving from the aorta, while the other end
(uterine artery) originates from the internal iliac artery. The bilateral arrangement of the uterine
circulation creates redundancy and maintains a constant blood supply even in cases of occlusion
of a vessel. Perpendicular vessels emanate from the main uterine artery and form the arcuate
arteries, surround the uterus and give rise to smaller radial arteries that penetrate the
myometrium. The radial arteries then branch in to the basal and/or spiral arteries at the
myoendometrial border. The basal arteries form a vascular network along the myoendometrial
border, while the spiral arteries enter deeper into the endometrium and end in capillaries. These
capillaries are eventually drained by venules which subsequently become veins that enter the
inferior vena cava. In rodents, the main utero-ovarian vessels are typically parallel to the uterine
wall within a layer of connective tissue known as the mesometrium. Branches from the uteroovarian vessels connect the arcuate loops with the uterine wall. These radial arteries may then
enter the uterine or widen before entering the placenta via endovascular trophoblast invasion.

C. Maternal-fetal vasculature. Vertebrates develop a system of membranes that surround the
developing fetus. Apposition or fusion of these fetal membranes with the uterine mucosa, for
maternal-fetal exchange, triggers the formation of the placenta. The placenta is a transient organ
with significant structural and functional species variability with one common characteristic; the
presence of two (maternal and fetal) discrete circulations separated by several tissue layers
throughout pregnancy known as the placental barrier. This barrier typically consists of:
1) Blastocyst wall (trophoblast), which eventually becomes the chorion after fusion with the fetal
mesenchyme.
2) Allantois, which represents the embryonic urinary bladder.
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3) Yolk sac, which represents an extension of the gut.
These membranes are surrounded by the amnion which forms a membranous sac derived from
the fetus. Originally, the placenta was believed to be a barrier organ responsible primarily for the
maternofetal exchange of waste and nutrients. However, the placenta is fundamental in a wide
gamut of processes:
1) Excretion, water balance and pH regulation
2) Catabolic and resorptive functions
3) Synthesis and secretion of hormones
4) Metabolic and secretory functions
5) Hematopoiesis
6) Heat and gas transfer
7) Immunological functions
In humans, the placenta is characterized by a tree-like branching pattern of the chorion, resulting
in the formation of the placental villous tree. These villi fit into corresponding endometrial crypts
or are directly surrounded by maternal blood. Therefore, the functional unit of the human placenta
is defined as the chorionic villus, which contains the syncytiotrophoblasts/cytotrophoblasts, villous
stromal, and fetal vascular endothelium that separate maternal blood from the fetal circulation.
The structure of the rodent placenta is often described as “labyrinthine” and is characterized by
the formation of web-like channels by the trophoblasts that are filled with maternal blood or fetal
capillaries.
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The uteroplacental circulation (Figure 2) begins with the flow of maternal blood into the intervillous
space via the decidual spiral arteries. It is at this point that gas and nutrient exchange occurs in
the intervillous space. Maternal arterial blood forces deoxygenated blood into the endometrial and
uterine veins into the maternal circulation. The feto-placental circulation consists of the umbilical
cord that attaches the placenta to the fetus. The cord is not directly attached to the maternal
circulation but joins the placenta which mediates the transfer of substances to and from the
maternal circulation. The umbilical cord contains one vein (umbilical vein) and two arteries
(umbilical arteries). The umbilical vein is responsible for carrying oxygenated, nutrient-rich blood
from the placenta to the fetus, while the umbilical arteries carry deoxygenated, nutrient-depleted
blood from the developing fetus to the placenta. The functional units that allow the maternal-fetal
exchange of nutrients and oxygen is the terminal villi. For this reason, the flow of maternal-fetal
blood in humans is referred to as multivillous.

5. Conclusion.
Evidence has accumulated that ENM exposure negatively and diversely affects cardiovascular
health. Cardiovascular endpoints associated with pulmonary ENM exposure however do not
depend solely on translocation to the systemic circulation. Dysfunction may occur via activation
of the immune system, resulting in the release of inflammatory mediators in the systemic
circulation or via dysregulation of the autonomic nervous system [88]. Therefore, in investigating
the cardiovascular impact of ENM it is critical to bear in mind that all these systems may be at
play, at differing intensities over time. The severity and location of these effects is heavily
dependent upon the physicochemical properties of the ENM in question and the physiological
conditions of the cardiovascular continuum. A major target of ENM exposure is the endothelium,
a one cell-thick layer present in all vascular compartments and responsible for the secretion of
and response to paracrine, autocrine, and endocrine substances. ENM exposure has been
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implicated with impaired endothelium-dependent dilation due to decreased nitric oxide
bioavailability resulting from ROS generation or via inflammatory mechanisms.

Effect of Size
Cardiovascular toxicity is inversely correlated to particle size, most likely due to the increased
ability of smaller particles to deposit and penetrate deep within the site of entry, traverse biological
barriers, and access the systemic circulation. Even though systemic translocation of ENM from
the site of entry may not be significant [81], intentional introduction of ENM or modification of ENM
properties may increase significantly the proportion entering the circulation [94] and accumulating
at a target tissue [62]. Alternatively, the high number of particles or the large surface area
available for interactions after an exposure may play a role. Future studies focused on the most
appropriate dose-metric for these issues are warranted.

The decreased size of ENM also means an increased reactivity, a phenomenon which becomes
exceedingly important when considering metal oxides ENM and their catalytic ability to generate
ROS via Fenton chemistry. Increased reactivity may also increase the likelihood for ENM to
interact with biomolecules, thus increasing their potential immunogenicity and overall toxicity.

Effect of Shape
ENM shape is also a key determinant of cytotoxicity. Carbonaceous ENM, particularly SWCNT
and MWCNT are classical examples of high aspect-ratio ENM. Some studies have shown that
SWCNT exhibit greater immunogenicity and cytotoxicity than MWCNT because of their unique
physical conformation [55]. Their systemic, vascular effects and persistence may be a result of
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this structural property. An increased aspect-ratio could prevent clearance by cells of the immune
system and promote deposition within the vasculature particularly at bifurcations or in regions of
turbulent flow. ENM with higher aspect-ratios have a greater tendency to settle out of centerline
blood flow and deposit within the vascular wall compared to their spherical counterparts.

Effect of Surface Charge and Chemistry
Surface charge and chemistry may influence the biological effects of ENM. Clearance by the
kidneys, particle agglomeration and the interaction with both immune and cardiovascular
components are impacted by ENM surface properties. Charged particles elicit a more significant
inflammatory response via activation of the mononuclear phagocytic system and the caspaseinflammasome axis. ENM functionalization via the addition of specific chemical moieties may
greatly dictate the interaction with physiological biomolecules and therefore the formation of a
protein corona. Within the vasculature, changes in ENM surface chemistry can affect ENM
agglomeration which in turn may increase ENM plasma half-life and vascular deposition.

Reactivity - Tissue Specificity
The impact of ENM exposure on the systemic circulation and cardiovascular health are tissue
specific. The macrocirculation function as blood conduits and pressure reservoirs. While these
functions are fundamental for cardiovascular health, they do not depend on significant degrees of
vasomotion and regulation by central and local mechanisms. Therefore, ENM deposition in the
vascular system may exacerbate preexisting cardiovascular conditions such as atherosclerosis
[2]. Damage to the macrocirculation leads to a decreased vascular compliance and consequently
an increase in afterload. A prolonged increase in afterload and vascular resistance may lead to
increased work by the heart and eventually cardiac failure.
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The microcirculation is a major regulatory functional component of the cardiovascular system. Its
fundamental role in the generation of total peripheral resistance, immune response and waste
exchange are well known. ENM deposition in arterioles may lead to impaired vascular reactivity,
thus affecting the ability of these vessels to generate resistance to blood flow This impaired
reactivity could have major effects on tissue perfusion and nutrient-waste exchange in capillaries.
ENM deposition within capillaries may severely impact vascular permeability by damaging
endothelial cells cytoskeleton. The release of ions by ENM could affect the subtle balance
between capillary and interstitial fluid colloid and oncotic pressures. Localization of ENM within
venules may promote leukocytic infiltration and trigger an innate immune response and the
release of proinflammatory mediators. Damage to venules may increase capillary filtration and
hematocrit.

In conclusion, the field of cardiovascular nanotoxicology is still in its relative infancy. With the
increasing presence of ENM in everyday consumer products, the risk of unintentional
occupational and domestic exposure remains very high. The use of in vitro models, different
exposure conditions and ENM characteristics may partly account for the incongruity in the
toxicological research. However, the advent of new and more powerful experimental tools such
as high throughput screening may prove beneficial for the assessment of the vascular effects of
ENM. Whatever directions future research takes, the regional heterogeneity and unique ENM
properties, as well as their interactions must be directly addressed if nanotechnology is to make
its greatest contribution to human health.
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While the current literature consistently points towards an impairment in overall cardiovascular
function associated with ENM exposure, the cardiovascular system is comprised of various
segments that are fundamentally different in their function and structure. The present studies
were designed to evaluate 1) the effect of ENM exposure on different levels of the vasculature to
identify the most sensitive discrete vascular components to ENM toxicity, and 2) identify potential
mechanisms involved in the microvascular and reproductive effects of pulmonary exposure. The
findings of these studies should further contribute to our knowledge of the interaction among the
different microvascular control mechanisms and how ENM exposure alters these mechanisms.

Purpose of Dissertation
Given the almost ubiquitous inclusion of ENM in everyday products, identification of the biological
effects of these materials is important if the nanotechnology industry is to reach its full potential.
Nano-TiO2 is by far the most widely used ENM [89] Therefore, the present studies were designed
to study: 1) the differential effects of nano-TiO2 on discrete segments of the vasculature and
identify the most sensitive segments to pulmonary ENM exposure, 2) the acute microvascular
and immunological effects of pulmonary nano-TiO2 exposure and provide a mechanistic basis for
the observed outcomes, 3) the effects of gestational pulmonary nano-TiO2 exposure on placental
hemodynamics and the potential fetal repercussions.
The specific aims of the studies are listed below.
Study 1
The aim of this study was to identify the most sensitive segments of the vasculature to pulmonary
ENM exposure. Sprague-Dawley rats were intratracheally instilled with 20 g, 100 g or 200 g
nano-TiO2. 24 hours post-exposure vascular reactivity of the thoracic aorta, common femoral
artery, 3rd order mesenteric arterioles was determined by measurement of isometric tension
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generation using wire myography in vitro. Furthermore, vascular reactivity of 4th and 5th order
mesenteric arterioles was assessed using the isolated microvessel technique. These
preparations provided an understanding of the vascular mechanisms (e.g. endotheliumdependent, endothelium -independent and adrenergic) influenced by nano-TiO2 exposure.
Furthermore, this study identifies the most sensitive vascular levels to pulmonary exposure.

Study 2
The aims of this second study was to identify the effect of pulmonary ENM exposure on innate
lymphoid cell function and the effect on uterine arteriolar function. Virgin, female, Sprague-Dawley
rats were intratracheally instilled with 100 μg nano-TiO2. Serial blood samples were obtained at
0, 1, 2 and 4 hours post-exposure for cytokine analysis. Lung Group 2 innate lymphoid cell number
and interleukin 33 levels in bronchoalveolar lavage fluid and serum were determined 4 hours after
exposure. 24 hours post-exposure uterine radial arterioles were assessed using the isolated
microvessel technique. This preparation provided an understanding of the arteriolar alterations
(e.g. endothelium-dependent, endothelium-independent and adrenergic) that follow nano-TiO2
exposure. This study identifies the acute inflammatory time-course associated with pulmonary
ENM exposure, provides a potential mechanism linking the observed microvascular outcomes
with the pulmonary effects and proposes a role for Group 2 innate lymphoid cells.

Study 3
Lastly, the aim of this study was to determine the effects of gestational ENM exposure on placental
vascular resistance and umbilical vascular function. Pregnant Sprague-Dawley rats were exposed
via whole-body inhalation to nano-TiO2 on GD 11 for 7 days (6h/exposure) for a cumulative dose
of 525 ± 16 μg. 24 post-exposure, placentas, umbilical artery and vein were assessed using the
isolated microvessel preparation. This preparation provided an understanding of the arteriolar and
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placental alterations (e.g. endothelium-dependent, endothelium-independent) that follow
gestational nano-TiO2 exposure. Overall, this study provided information regarding the influence
of nano-TiO2 on the function of the maternal-fetal microcirculation.
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Figure 1. Schematic representation of the cardiopulmonary system and identification of
locations for ENM influences/activities. Black arrows: blood flow direction. Red represents
oxygenated blood. Blue represents deoxygenated blood. 1) Extrapulmonary translocation to
systemic circulation. 2) Arterial bifurcation and impaction. 3) Eddy current turbulence and
impaction. 4) Segre-Silberg effect and plasma settling. 5) Systemic capillary translocation and
tissue deposition. 6) Venular inflammatory signaling. 7) Venous settling. For simplicity, only one
systemic tissue is depicted.

Figure 2. Schematic representation of the maternal-fetal circulation in rodents. Diagram
showing the maternal-fetal arterial (red) and venous circulation (blue) and the direction of blood
flow and the location of the trophoblast layer in rodents.
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Abstract:
A growing body of research links engineered nanomaterial (ENM) exposure to adverse
cardiovascular endpoints. The purpose of this study was to evaluate the impact of ENM exposure
on vascular reactivity in discrete segments so that we may determine the most sensitive levels of
the vasculature where these negative cardiovascular effects are manifest. We hypothesized that
acute nano-TiO2 exposure differentially affects reactivity with a more robust impairment in the
microcirculation. Sprague-Dawley rats (8-10 weeks) were exposed to nano-TiO2 via intratracheal
instillation (20 µg, 100 µg, or 200 µg suspended per 250 µl of vehicle) 24 hours prior to vascular
assessments. A serial assessment across distinct compartments of the vascular tree was then
conducted.

Wire myography was used to evaluate macrovascular active tension generation

specifically in the thoracic aorta, the femoral artery and 3rd order mesenteric arterioles. Pressure
myography was used to determine vascular reactivity in 4th and 5th order mesenteric arterioles.
Vessels were treated with phenylephrine (PE), acetylcholine (ACh), and sodium nitroprusside
(SNP).

Nano-TiO2 exposure decreased endothelium-dependent relaxation in the thoracic aorta and
femoral arteries assessed via ACh by 54 ± 12%, and 25 ± 6%, respectively. Relaxation of third
order mesenteric arterioles was impaired by 100 µg and 20 µg nano-TiO2 exposures with mean
reductions of 50 ± 9% and 68 ± 9%. Cholinergic reactivity of 4th and 5th order mesenteric arterioles
was negatively affected by nano-TiO2 with diminished dilations of 83 ± 13% after exposure to 200
µg nano-TiO2, 43 ± 13% after 100 μg nano-TiO2, and 49 ± 13% after 20 µg nano-TiO2.

Endothelium-independent relaxation was impaired in the thoracic aorta by 34 ± 3% induced by
exposure to 200 µg nano-TiO2 and a reduction in response of 49 ± 3% caused by 100 µg nano-
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TiO2. Femoral artery response was reduced by 18 ± 5%, while 3rd order mesenteric arterioles
were negatively affected by 20 µg nano-TiO2 with a mean decrease in response of 38 ± 10%.
This is the first study to directly compare the differential effect of ENM exposure on discrete
anatomical segments of the vascular tree. Pulmonary ENM exposure produced macro- and
microvascular dysfunction resulting in impaired responses to endothelium-dependent,
endothelium-independent, and adrenergic agonists with a more robust dysfunction at the
microvascular level. These results provide additional evidence of an endothelium-dependent and
-independent impairment in vascular reactivity.
Keywords: engineered nanomaterials, titanium dioxide, cardiovascular system, microcirculation,
endothelium
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Introduction:
Engineered nanomaterials (ENM) are most commonly defined as a homogeneous mixture of
anthropogenic materials possessing at least one dimension less than or equal to 100 nm [6] and
have historically been used in inhalation toxicology research as surrogates for environmental air
pollution studies to model ultrafine particulate matter exposures [23,30].

The continued

development of novel ENM with diverse physicochemical properties represents a growing
economic sector. Presently, the nanotechnology industry is one of the fastest growing markets
with an estimated projected worth of $75.8 billion by 2020 [20]. This increased prevalence of
ENM not only continues concerns over their safety and the potential adverse health outcomes
that may occur because of prolonged, unmitigated exposure but also warrants more thorough
toxicological assessments of their potential deleterious systemic effects.

Titanium dioxide (nano-TiO2) is amongst the most widely used nanomaterials, its optical
properties allow it to be used in consumer products such as topical sunscreens and cosmetics,
as well as industrial components including paints [36]. It is used commonly as a photocatalyst,
catalyst carrier, heat stabilizer and as a food additive [44].

Nano-TiO2 may also be used as a

drug carrier in nanomedicine [25].

Pulmonary nano-TiO2 exposure has been associated with systemic inflammation in vivo [5,11,43],
with dose-dependent overt inflammation characterized by a marked increase in proinflammatory
mediators and lung toxicity [15,43].
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The circulatory system can be grossly divided into two major components based on structure and
location: the macrocirculation and the microcirculation. The macrocirculation refers to the conduit
arteries and veins which connect the heart with the systemic organs and function as pressure and
blood reservoirs respectively. The microcirculation is a broad term encompassing all the vascular
tissue within a specific organ, including arterioles, the capillary network, and venules [27]. Its
fundamental function is the maintenance of an ideal internal environment for the controlled
exchange of nutrients and metabolic waste with the adjacent tissues. For this study, conduit
arteries and arterioles were chosen because they are major hemodynamic regulators and key
players in the maintenance of blood pressure, flow distribution and tissue perfusion [28,29].

The endothelium is a regulator of vascular homeostasis and is extremely sensitive to changes in
blood composition and hemodynamics [18]. Consisting of a monolayer of cells that functions as
a physical barrier for the exchange of materials between blood and tissues [4], it is also
responsible for the secretion of a variety of molecules, including prostacyclins [7], clotting factors
[31], and ectonucleotidases [26] that are important for the regulation of blood coagulation and
platelet function.

Endothelial cells also coordinate the recruitment of immune cells to sites of

injury or infection via both the production and release of cytokines [21], and the expression of
specific cell adhesion molecules on their apical surface that mediate leukocyte attachment and
extravasation [9,10,34,37]. While common to all vascular segments, endothelial cells show
significant morphological and functional heterogeneity throughout the vasculature, between
different organs, and between neighboring endothelial cells of the same organ and blood vessel
type [2]. These phenotypic differences may account for the differential and vascular-bed specific
responses of endothelial cells to specific toxicants.

55

We have previously established that nano-TiO2 exposure is associated with systemic vascular
dysfunction [12,19,38]. However, the relative sensitivity to ENM of each vascular segment is not
known. Therefore, the aim of this study is to assess the effects of three occupationally relevant
nano-TiO2 concentrations on both the macrocirculation and microcirculation from a functional
perspective via wire and pressure myography. 100 μg of nano-TiO2 was selected based on
previous work conducted by our group [23]. Additionally, 200 μg and 20 μg were chosen for this
study to identify the maximum and minimum observed dose responses. The most sensitive
vascular level to nano-TiO2 exposure was subsequently determined. Based on our previous
results we hypothesize that nano-TiO2 exposure impairs endothelium-dependent responsiveness
and that this effect is more pronounced in the microcirculation.
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Methods:
Nanomaterial Characterization
Nano-TiO2 P25 powder, obtained from Evonik (Aeroxide TiO2, Parsippany, NJ), has previously
been shown to be a mixture composed primarily of anatase (80%) and rutile (20%) TiO2, with a
primary particle size of 21 nm and a surface area of 48.08 m2/g [23,32,33].

Experimental Animals and Exposure
Male (8-10 weeks) Sprague–Dawley rats were purchased from Hilltop Laboratories (Scottdale,
PA) and housed at WVU with 12:12 h light–dark cycle and regulated temperature. Rats were
allowed ad libitum access to food and water. All procedures were approved by the Institutional
Animal Care and Use Committee of West Virginia University and abide by the standards set forth
in the “Guide for Care and Use of Laboratory Animals” of the National Research Council of the
National Academies.

Bolus doses of nano-TiO2 (20 g, 100 g and 200 g) were suspended in 250 μL of vehicle
(Normosol and 5% fetal bovine serum) for intratracheal instillation (IT) 24 hours prior to
experimentation. Nano-TiO2 suspensions were sonicated over ice for 1 minute to ensure
increased dispersion. Sprague-Dawley rats were anesthetized using 5% isoflurane, placed on a
mounting stand and IT with 200 L of vehicle (negative control) or the nano-TiO2 suspensions.
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Mean Arterial Pressure (Map) Acquisition
Rats were anesthetized with isoflurane gas (5% induction, 3–3.5% maintenance) and placed on
a heating pad to maintain a 37 °C rectal temperature. The trachea was intubated to ensure an
open airway and the right carotid artery was cannulated to acquire MAP. PowerLab830 (AD
Instruments) was used to record MAP.

Wire Myography Arterial Ring Preparation
The thoracic aorta, common femoral artery, 3rd order mesenteric arterioles were dissected and
immediately placed in ice cold Ringer`s solution. 2-3 mm segments were cut and mounted in each
wire myograph chamber (AD Instruments - DMT 620M) containing 5 mL of physiological salt
solution (PSS; 119 mM NaCl, 4.7 mM KCl, 1.18 mM KH2PO4, 1.17 mM MgSO4, 2.5 mM, CaCl2,
25 mM NaHCO3, 0.027 mM EDTA, and 5.5 mM glucose) at pH 7.4 and bubbled with 95% O2 /
5% CO2 at 37°C. After 30 minutes of equilibration, maximum contractile response was determined
by using high-potassium PSS (K+PSS; 123.7 mM KCl, 1.18 mM KH2PO4, 1.17 mM MgSO4, 2.5
mM, CaCl2, 25 mM NaHCO3, 0.027 mM EDTA, and 5.5 mM glucose). Vessels were then washed
twice with PSS and allowed to relax until initial tension was reached. Contractile responses were
determined via cumulative additions of 50 L of phenylephrine (PE-1x10-9-1x10-4 M). Relaxation
responses were evaluated via cumulative addition of 50 L acetylcholine (ACh) or sodium
nitroprusside (SNP) (1x10-9-1x10-4 M).

Statistics
Point-to-point differences in the dose-response curves were evaluated using two-way repeated
measures analysis of variance (ANOVA) with a Tukey`s post-hoc analysis when significance was
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found. The slopes of the dose response curves were determined through nonlinear regression.
The animal characteristics, vessel characteristics and dose response curve slopes were analyzed
using a one-way ANOVA with a Tukey post-hoc analysis when significance was found. All
statistical analysis was completed with GraphPad Prism 5 (San Diego, CA) and SigmaPlot 11.0
(San Jose, CA). Significance was set at p < 0.05, n is the number of arterioles, and N is the
number of animals.

Wire Myography Calculations
Maximum tension was defined as the tension developed by the vessels with K+PSS. Tension with
agonists (ACh, SNP or PE) was recorded and the percentage of maximum tension generation
was calculated using the following formula:

Percentage Maximum Tension (%) = (

𝑇𝑒𝑛𝑠𝑖𝑜𝑛 𝑤𝑖𝑡ℎ 𝑎𝑔𝑜𝑛𝑖𝑠𝑡𝑠 (𝑚𝑁)
) x 100%
𝑀𝑎𝑥𝑖𝑚𝑢𝑚 𝑡𝑒𝑛𝑠𝑖𝑜𝑛 (𝑚𝑁)

The response of the different arterial branching orders was quantitatively assessed and compared
by using the slope of the individual dose-response curves as previously reported [45].

Pressure Myogaphy Arteriolar Preparation
The mesentery was excised and placed in a dissecting dish with PSS maintained at 4 °C. 4th and
5th order mesenteric arterioles were isolated, transferred to a vessel chamber, cannulated
between two glass pipettes (outer diameter 60 µm), and secured by means of silk sutures in the
vessel chamber (Living Systems Instrumentation, Burlington, VT). The chamber was superfused
with fresh oxygenated (5% CO2/21% O2) PSS and warmed to 37 °C. Arterioles were pressurized
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to 60 mm Hg using a servo control system and extended to their in situ length. Internal and
external arteriolar diameters were measured using video calipers (Colorado Video, Boulder, CO).

Arteriolar Reactivity
Arterioles were equilibrated for 1 hour prior to experimentation.

Arterioles with < 20%

spontaneous tone were not analyzed. Contractile responses were determined via cumulative
additions of 50 L of phenylephrine (PE) (1x10-9 - 1x10-4) M. Relaxation responses were evaluated
via cumulative addition of 50 L acetylcholine (ACh) or sodium nitroprusside (SNP) (1x10-9 -1x104

M). The steady state diameter of the vessel was recorded for at least 2 min after each dose.

After each dose curve was completed, the vessel chamber was washed to remove excess
chemicals by carefully removing the superfusate and replacing it with fresh warmed oxygenated
PSS. After all experimental treatments were complete, the PSS was replaced with Ca2+-free PSS
until maximum passive diameter was established.

Pressure Myography Calculations
All measurements were conducted during steady state conditions, with steady state being defined
as the interval during which blood vessels maintained a stable tone for 1 minute or more. Vessels
were washed twice with PSS between individual dose - response treatments and allowed
approximately 10 minutes for equilibration or until original tone was developed.

Data are

expressed as means ± standard error. Spontaneous tone was calculated by the following
equation:

𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠 𝑡𝑜𝑛𝑒 (%) = {
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(𝐷𝑚 − 𝐷𝑖)
} 𝑥 100
𝐷𝑖

, where Dm is the maximal diameter and Di is the initial steady state diameter recorded prior to
the experiment. Active responses to pressure were normalized to the maximal diameter using the
following formula:
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 = 𝐷𝑠𝑠/𝐷𝑚
, where Dss is the steady state diameter recorded during each pressure change. The
experimental responses to ACh, and SNP are expressed using the following equation:

𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟 (𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑚𝑎𝑥𝑖𝑚𝑎𝑙 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟) = {

(𝐷𝑠𝑠 − 𝐷𝑐𝑜𝑛)
} 𝑥 100
(𝐷𝑚 − 𝐷𝑐𝑜𝑛)

, where DCon is the control diameter recorded prior to the dose curve, DSS is the steady state
diameter at each dose of the curve. The experimental response to PE is expressed using the
following equation:

𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟 (𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑚𝑎𝑥𝑖𝑚𝑎𝑙 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟) = {

(𝐷𝑐𝑜𝑛 − 𝐷𝑠𝑠)
} 𝑥 100
(𝐷𝑐𝑜𝑛)

Wall thickness (WT) was calculated from the measurement of both inner (ID) and outer (OD)
steady state arteriolar diameters at the end of the Ca2+ free wash using the following equation:
𝑊𝑇 = (𝑂𝐷 − 𝐼𝐷)/2
Wall-to-lumen ratio (WLR) was calculated using the following equation:
𝑊𝐿𝑅 = 𝑊𝑇/𝐼𝐷
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Results:
Animal and Vessel Characteristics
No significant changes were observed in age, MAP, heart rate and body weight between control
and exposure groups (Table 1). Active inner diameter of 4th and 5th order mesenteric arterioles
exposed to 200 µg of nano-TiO2 (134 ± 11 µm) and 100 µg of nano-TiO2 (128 ± 19 µm) were
significantly different from control values (115 ± 10 µm), while passive diameter remained
unchanged. This increase in diameter was associated with a decreased initial vascular tone
(Table 2).

Endothelium-Dependent Reactivity
200 µg of nano-TiO2 significantly impaired endothelium-dependent relaxation of thoracic aorta
(Figure 1 A) with a mean decrease in response to ACh of 54 ± 12%. No significant effects were
seen at 100 µg and 20 µg of nano-TiO2 (Figure 1 A).

Femoral arteries from exposed animals showed a reduced cholinergic response solely at the
lowest exposure concentration (20 µg nano-TiO2 /250 µL of vehicle) of 25 ± 6% (Figure 1 B).
Further, 100 µg and 20 µg nano-TiO2 exposure resulted in a mean reduction in relaxation of third
order mesenteric arterioles of 50 ± 9% and 68 ± 9% respectively (Figure 1 C). Lastly, cholinergic
reactivity of 4th and 5th order mesenteric arterioles was negatively affected by nano-TiO2 with
diminished dilations of 83 ± 13% after exposure to 200 µg nano-TiO2, 43 ± 13% after 100 μg nanoTiO2, and 49 ± 13% after 20 µg nano-TiO2 (Figure 1 D).
In order to consider the fullest scope of the biological response across the discrete entities of the
vasculature, the slope of the individual dose-response curves was utilized as a means of
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numerically quantifying vascular reactivity (Figure 2) as previously shown [25,45]. Exposure to
200 µg of nano-TiO2 decreased sensitivity to ACh from 16 ± 1 M-1 to 4 ± 1 M-1. Similarly, vascular
reactivity of femoral arteries was diminished from the control value of 12 ± 2 M-1 to 8 ± 4 M-1 and
7 ± 3 M-1 with 200 µg and 100 µg nano-TiO2 respectively. Third order mesenteric arterioles
showed a dose dependent reduction in ACh sensitivity from control levels (17 ± 3 M-1) with 100
µg nano-TiO2 having the greatest deleterious effect (3 ± 1 M-1), while 200 µg nano-TiO2 and 20
µg nano-TiO2 reduced responsiveness to 7 ± 3 M-1 and 3 ± 1 M-1. 4th and 5th mesenteric arterioles
showed the greatest decrease in vascular reactivity from controls (15 ± 2 M-1) particularly with
200 µg nano-TiO2 (-12 ± 5 M-1) and 20 µg nano-TiO2 (-2 ± 1 M-1), while vessels exposed to 100
µg nano-TiO2 showed slight ACh sensitivity (1 ± 0.4 M-1). These results provide additional
evidence of an endothelium-dependent effect associated with nanomaterial exposure.

The

heterogeneity in impairment across the vasculature indicates the microcirculation as the prime
site where these effects are most markedly manifest.

α-adrenergic Sensitivity
In contrast to endothelium-dependent relaxation, no point to point differences were seen in αadrenergic responses across all levels of the vasculature between nano-TiO2 exposed and control
groups (Figure 3 A-D). However, slope analysis, wherein the entire continuum of the vascular
PE responses is assessed, revealed significant differences in vascular sensitivity induced by
nano-TiO2 (Figure 4). Aortic PE sensitivity was increased by exposure to 100 µg nano-TiO2 (11
± 1 M-1) with respect to control values (14 ± 0.6 M-1). Significantly augmented adrenergic
responses were seen in the femoral artery with 100 (9 ± 3 M-1) and 20 µg nano-TiO2 (9 ± 2 M-1).
Also, 200 µg nano-TiO2 (6 ± 2 M-1) and 20 µg nano-TiO2 (6 ± 1 M-1) caused increased vascular
reactivity of 3rd order mesenteric arterioles relative to controls (2 ± 3 M-1). Lastly, 4th and 5th
mesenteric arterioles from exposed animals showed a clear pro-constrictive effect particularly at
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200 µg nano-TiO2 (20 ± 2 M-1) and 20 µg (24 ± 2 M-1), with 100 µg (20 ± 2 M-1) leading to responses
similar to controls (16 ± 1 M-1) (Figure 4). This effect is consistent with previous work [12,42] and
confirms a potential effect on sympathetic tone , associated with ENM exposure.

Endothelium-Independent Reactivity
Endothelium-independent relaxation assessed via the spontaneous NO donor SNP was impaired
in the thoracic aorta with a mean decrease in response of 34 ± 3% induced by exposure to 200
µg nano-TiO2 and a reduction in response of 49 ± 3% caused by 100 µg nano-TiO2 (Figure 5 A).
Similarly, the response of the femoral artery to SNP was reduced by 18 ± 5% (Figure 5 B). 3rd
order mesenteric arterioles were negatively affected by 20 µg nano-TiO2 with a mean decrease
in response of 38 ± 10% (Figure 5 C). It is interesting to note that slope analysis demonstrated
a decrease in SNP sensitivity only in thoracic aorta at 200 µg (21 ± 2 M-1) and 100 µg (19 ± 2 M1

) nano-TiO2 compared to control (26 ± 3 M-1) (Figure 6). Similarly, 4th and 5th mesenteric arteriolar

sensitivity to SNP was significantly reduced from (18 ± 2 M-1) to (16 ± 2 M-1) by exposure to 20 µg
nano-TiO2.

This is consistent with previous findings where impairments in endothelium-

independent dilation in the microcirculation is not noted [13,22,39].

64

Discussion:
This is the first study to directly compare the differential effect of ENM exposure on discrete
anatomical segments of the vascular tree. Pulmonary ENM exposure produced macro- and
microvascular dysfunction resulting in impaired responses to endothelium-dependent,
endothelium-independent and adrenergic agonists. The major finding of this paper is that acute
nano-TiO2 pulmonary exposure results in a more robust dysfunction at the microvascular level,
and this is not simply because arterioles possess greater reactivity than arteries.

The microcirculation is critical in the regulation of the vascular internal environment for the
controlled exchange of nutrients and metabolic waste with the adjacent tissues. Specifically,
arterioles are major hemodynamic regulators and key players in the maintenance of blood
pressure and flow distribution [28,29].

Disruptions in microvascular function are commonly

associated with health consequences such as hypertension and diabetes, and this is largely due
to endothelial dysfunction [35].

The pronounced effect of ENM exposure on the microcirculation may be due to the propensity of
nanoparticles to accumulate preferentially in this vascular compartment. Considerable evidence
exists suggesting that after the initial exposure, nanomaterials tend to translocate and accumulate
systemically [16,17].

Due to the existing hydrodynamic influences present within the

microcirculation, it has been hypothesized that ENM deposition would likely be highest in the
arterioles [41]. Within arterioles, ENM may directly impair vascular function via generation of free
radicals, decreasing NO bioavailability, NO synthase uncoupling, or by altering sympathetic tone.
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Cholinergic activity was assessed using ACh. In normal conditions, ACh activates endothelial
NO synthase (eNOS) by stimulating the release of intracellular calcium. L-Arginine is converted
to L-citrulline by eNOS with the production of NO. eNOS requires a number of cofactors, including
NADPH, FAD, calcium, calmodulin, and BH4. NO subsequently diffuses into vascular smooth
muscle cells and stimulates guanylate cyclase, ultimately resulting in cGMP production and
vasodilation. In this study, reduced reactivity was seen in the thoracic aorta, femoral artery, 3rd
order mesenteric arterioles and 4th/5th mesenteric arterioles. These effects are consistent with
previous results obtained by our group and others [24,40,42]. It is interesting to note, however,
that exposure to 200 µg nano-TiO2 resulted in a complete reversal of the vasodilatory response
by 4th/5th mesenteric arterioles, potentially indicating severe irreparable damage to the endothelial
layer.

The endothelium is a major regulatory component common to all levels of the vasculature and
plays a critical role in the control of vascular tone, the inflammatory response, maintenance and
regulation of blood fluidity, permeability, and angiogenesis [3]. Due to the significant role played
in vascular homeostasis, it is becoming increasingly recognized that the endothelium is involved
in most disease conditions, either as a primary determinant of pathophysiology or as a result of
collateral damage [1].

No point-to-point impairments were seen in the response to the α-adrenergic agonist PE.
However, when considering the whole continuum of the vascular responses to this agonist, a
prevalent increase in sensitivity, particularly at the microvascular level was observed (Figure 4),
consistent with previous work [12,42].
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Lastly, endothelium-independent dysfunction was observed primarily in the macrocirculation,
including the thoracic aorta, femoral artery, and 3rd order mesenteric arterioles (Figures 5 and 6).
This differential effect on vascular smooth muscle response in the macrocirculation may be
caused by the turbulent flow patterns characteristic of this segment which contribute to an
increased likelihood of deposition and impaction of ENM agglomerates particularly at large artery
bifurcations [41].

Dysfunction in vascular smooth muscle following particulate matter exposure was first reported in
pulmonary arteries by Courtois et al. [8]. Previous work attributed this effect to a proinflammatory
response triggered by particulate matter exposure, while other studies linked vascular dysfunction
to an increase in oxidative stress [14].

Historically, the adverse systemic effects associated with pulmonary ENM exposure have been
ascribed to a host inflammatory response, direct particle-tissue interactions and/or autonomic
dysregulation [30]. The observed macro- and microvascular dysfunction could be associated with
either impaired NO production, a decrease in NO bioavailability caused by the generation of
reactive oxygen species within the vascular wall, a shift in arachidonic acid metabolites or
vascular smooth muscle impairment or a combination of these mechanisms. It is outside the
scope of this study to determine the mechanisms underlying the vascular endpoints herein
reported, and future experiments are necessary to elucidate these mechanisms.

While the results of this study provide further indications of the microvascular effects associated
with ENM, it is admittedly not without its limitations. Wire myography assesses the tension
generated by vascular rings under isometric tension and therefore caution should be taken when
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interpreting the results obtained. This is particularly so for conduit arteries, in which changes in
wall tension do not explicitly translate into vasomotion. Further, the use of in vitro techniques to
evaluate vascular reactivity eliminates neurogenic and hormonal influences which also play an
important role in the mechanism of ENM cardiovascular toxicity. Therefore, future experiments
utilizing ex vivo preparations (such as intravital microscopy) may be more appropriate to obtain a
more thorough assessment.
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Figure Legends:
Figure 1. Endothelium – dependent dilation is impaired by intratracheal instillation of nanoTiO2. ACh-induced vascular reactivity in A) Aorta, B) Femoral artery, C) 3rd order mesenteric
arterioles, and D) 4th and 5th mesenteric arterioles (n = 10-11). Statistics were analyzed with twoway ANOVA (P ≤ 0.05). * Sham control group vs. nano-TiO2 exposed groups.

Figure 2. ACh sensitivity and vascular reactivity are decreased by nano-TiO2 exposure. Bar
graphs showing the individual slope values for sham control and exposed vessels (n = 911). Statistics were analyzed with two-way ANOVA (P ≤ 0.05). * Sham control group vs. nanoTiO2 exposed groups.

Figure 3. α-adrenergic response to PE is not affected by nano-TiO2. PE response in A) Aorta,
B) Femoral artery, C) 3rd order mesenteric arterioles, and D) 4th and 5th mesenteric arterioles (n =
10-11). Statistics were analyzed with two-way ANOVA (P ≤ 0.05). * Sham control group vs. nanoTiO2 exposed groups.

Figure 4. PE sensitivity are augmented by nano-TiO2 exposure. Bar graphs showing the
individual slope values for sham-control and exposed vessels (n = 10-11). Statistics were
analyzed with two-way ANOVA (P ≤ 0.05). * Sham control group vs. nano-TiO2 exposed groups.

Figure 5. Endothelium-Independent dilation and vascular smooth muscle function is not
impaired by nano-TiO2 exposure. SNP response in A) Aorta, B) Femoral artery, C) 3rd order
mesenteric arterioles, and D) 4th and 5th mesenteric arterioles (n = 10-11). Statistics were analyzed
with two-way ANOVA (P ≤ 0.05). * Sham control group vs. nano-TiO2 exposed groups.
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Figure 6: SNP-induced vascular reactivity is unaffected by nano-TiO2 exposure. Bar graphs
showing the individual slope values for sham-control and exposed vessels (n = 10-11).
Statistics were analyzed with two-way ANOVA (P ≤ 0.05). * Sham control group vs. nano-TiO2
exposed groups.
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Table 1: Animal Characteristics

Values are mean ± SEM; N, number of animals
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Table 2: Arteriolar Characteristics

Values are mean ± SEM; n, number of vessels
*p ≤ 0.05 vs Sham Control
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Abstract:
The cardiovascular effects of pulmonary exposure to ENM are poorly understood, and the
reproductive consequences are even less understood. Inflammation remains the most frequently
explored mechanism of ENM toxicity. However, the key mediators and steps between lung
exposure and uterine health remain to be fully defined. The purpose of this study was to
determine the uterine inflammatory and vascular effects of pulmonary exposure to nano-TiO2. We
hypothesized that pulmonary nano-TiO2 exposure initiates a Th2 inflammatory response
mediated by Group II innate lymphoid cells (ILC2), which may be associated with an impairment
in uterine microvascular reactivity. Female, virgin, Sprague-Dawley rats (8-12 weeks) were
exposed to 100 µg of nano-TiO2 via intratracheal instillation 24 hours prior to microvascular
assessments. Serial blood samples were obtained at 0, 1, 2 and 4 hours post-exposure for
multiplex cytokine analysis. ILC2 numbers in the lungs were determined. ILC2s were isolated and
phosphorylated nuclear factor kappa-light-chain-enhancer of activated B cells (NF-ĸB) levels
were measured. Pressure myography was used to assess vascular reactivity of isolated radial
arterioles. Pulmonary nano-TiO2 exposure was associated with an increase in IL-1ß, 4, 5 and 13
and TNF- α 4 hours post-exposure, indicative of an innate Th2 inflammatory response. ILC2
numbers were significantly increased in lungs from exposed animals (2 ± 0.2%) compared to
controls (0.2 ± 0.2%). Phosphorylation of the transactivation domain (Ser-468) of NF-κB in
isolated ILC2 and IL-33 in lung epithelial cells were significantly increased (127 ± 4% and 137 ±
11% of controls respectively) by nano-TiO2 exposure. Lastly, radial endothelium-dependent
arteriolar reactivity was significantly impaired (27 ± 12%), while endothelium-independent dilation
(7 ± 14%) and α-adrenergic sensitivity (8 ± 2%) were not altered compared to control levels.
Treatment with an anti- IL-33 antibody (1 mg/kg) 30 minutes prior to nano-TiO2 exposure resulted
in a significant improvement in endothelium-dependent dilation and a decreased level of IL-33 in
both plasma and bronchoalveolar lavage fluid. These results provide evidence that the uterine
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microvascular dysfunction that follows pulmonary ENM exposure may be initiated via activation
of lung-resident ILC2 and subsequent systemic Th2-dependent inflammation.
Keywords: engineered nanomaterials, titanium dioxide nanoparticles, microcirculation, innate
lymphoid cells, inflammation
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Introduction:
Reproductive toxicity is increasingly becoming recognized as a critical aspect of ENM safety.
However, the effects of ENM exposure on overall reproductive health have only recently been
addressed and become a focus of intense study by numerous groups [15,16]. As with other
observations of systemic biologic effects after pulmonary ENM exposures, reproductive effects
are equally susceptible but poorly understood. Our group has previously reported that nano-TiO2
inhalation is associated with uterine microvascular dysfunction [43], potentially deleterious
epigenomic alterations [44], and cognitive deficits in maternally exposed progeny [9]. While these
studies highlight the importance of identifying the maternal effects of ENM exposure, the
mechanisms linking such exposures to these negative reproductive and developmental outcomes
have yet to be fully elucidated.

In the last decade, innate lymphoid cells (ILC) have emerged as a novel population of tissuespecific effector cells with the ability to initiate and regulate the innate and adaptive branches of
the immune system [25,38]. ILCs are now divided into 3 distinct groups according to the pattern
of cytokine secretion; Group 1 ILC (ILC1) are predominantly tissue-resident cells capable of
secreting interferon gamma (IFN- γ) in the liver, gut, spleen, skin, peritoneum, and salivary gland
[2]. The role played by ILC1 in various immunological conditions remains unclear but is currently
under investigation. Group 2 ILCs (ILC2, also known as nuocytes, natural helper cells) secrete
IL-4, IL-5, IL-9, and IL-13 in response to damage-associated molecular patterns or “alarmins” and
have been implicated in the immune response to parasitic infections and in allergic airway
inflammation [51] to several environmental and anthropogenic agents [40,52]. Lastly, group 3
ILCs (ILC3) produce IL-22 and or IL-17, are enriched at mucosal sites, contribute to the
maintenance of the intestinal barriers, and may play a significant role in the promotion of the
inflammatory response and etiology of inflammatory bowel diseases [48,57]. One of the most
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important alarm signals secreted by cells is interleukin-33 (IL-33) [37]. IL-33 is a member of the
IL-1 family of cytokines expressed by both non-immune cells such as epithelial, endothelial,
smooth muscle cells, and fibroblasts [24], as well as immune effector cells including macrophages
and dendritic cells. Its role in directing the inflammatory response following pulmonary exposure
to carbon nanotubes [18,53,54], and ozone [26] have been previously reported. IL-33 has been
demonstrated [4] to induce the release of Th2 cytokines by immune cells including ILC2s in
asthmatic patients [17], and to induce airway hyperresponsiveness and increased pulmonary
resistance [6,12].

In view of the increasing number of studies indicating a crucial role for ILCs in the initiation of the
acute inflammatory response to environmental agents, the goal of this work was to provide initial
evidence of their potential involvement in the response to pulmonary ENM exposure. Therefore,
the purpose of this study was threefold. First, we identified the inflammatory and uterine
microvascular effects associated with acute pulmonary nano-TiO2 exposure. Second, we
determined the possible role played by ILC in the immune response mounted to acute pulmonary
nano-TiO2 exposure. Lastly, the microvascular and systemic effects of treatment with an IL-33
antibody (a key activator of ILC2) were determined. We hypothesized that pulmonary nano-TiO2
exposure initiates a Th2 inflammatory response mediated involving IL-33 and potentially involving
ILC2, which may be associated with a systemic impairment in uterine microvascular reactivity.
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Methods:
Nanomaterial Characterization
Nano-TiO2 P25 powder, obtained from Evonik (Aeroxide TiO2, Parsippany, NJ), has previously
been shown to be a mixture composed primarily of anatase (80%) and rutile (20%) TiO2, with a
primary particle size of 21 nm and a surface area of 48.08 m2/g [31], and a Zeta-potential of -56.6
mV [29]. Elemental composition analysis of the nano-TiO2 suspension was conducted via energy
dispersive spectroscopy.

Scanning electron microscopy was performed by diluting the nano-TiO2 1:100 with filtered distilled
water. 0.5 ml of the diluted particle solution was filtered onto a 0.2 µm polycarbonate filter. A
wedge-shaped portion of the polycarbonate filter was mounted onto carbon double stick tape
which was affixed to a 13 mm aluminum stub. The sample was sputter coated with gold-palladium
for two minutes. The sample was imaged using a Hitachi S4800 field-emission scanning electron
microscope (Tokyo, Japan).

Experimental Animals and Exposure
Female (8-10 weeks) Sprague – Dawley rats were purchased from Hilltop Laboratories
(Scottdale, PA) and housed in an AAALAC approved facility at West Virginia University (WVU)
with 12:12 h light – dark cycle and regulated temperature. Rats were allowed ad libitum access
to food and water. All procedures were approved by the Institutional Animal Care and Use
Committee of WVU.
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100 g of nano-TiO2 were suspended in 250 μL of vehicle (Normosol and 5% fetal bovine serum)
for IT 24 hours prior to experimentation. Nano-TiO2 suspensions were sonicated for 1 minute to
ensure homogenous distribution of nanoparticles. Rats were anesthetized using 5% isoflurane
and placed on a mounting stand. 250 L of the nano-TiO2 suspension was then instilled
intratracheally. Sprague - Dawley rats instilled with 250 μL of vehicle were used as controls.

Mean Arterial Pressure (MAP) Acquisition
Rats were anesthetized with isoflurane gas (5% induction, 2–3.5% maintenance). The animals
were placed on a heating pad to maintain a 37 °C rectal temperature. The trachea was intubated
to ensure an open airway and the right carotid artery was cannulated to acquire mean arterial
pressure (MAP). The MAP was measured via a pressure transducer and recorded by
PowerLab830 (AD Instruments, Colorado Springs, CO).

Multiplex Cytokine Panels of Serum and Bronchoalveolar Lavage Fluid
Whole blood (1-2 ml) was collected via tail vein puncture from exposed and control animals at
time 0, 1 hour, 2 hours, and 4 hours after exposure into EDTA vacutainers and centrifuged (1000
x g) to collect plasma which was flash-frozen in liquid nitrogen and stored at -80 ֯C until analysis.
Rats were euthanized, and tissues harvested for further analysis. Multi-spot inflammatory assays
were completed per manufacturer's directions (Meso Scale Diagnostics, Rockville, MD) for:
lipocalin-2, TSP-1, TIMP-1, MCP-1, interferon (IFN-γ), interleukin (IL)-1β, IL-4, IL-5, IL-6,
KC/GRO, IL-10, IL-13, and TNF-α.
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Immunohistochemistry
Gelatin-coated cover slips of serial tissue sections were incubated with anti-rabbit (1:100) IL-33
(Cloud-Clone Corp., Katy, TX) overnight at 4 ֯C, followed by 3 five-minute washes with cold PBS
with 0.1% Triton-X. The sections were then incubated with a FITC conjugated goat anti-rabbit
(1:100, Invitrogen, Carlsbad, CA) at 37 ֯C for one hour, followed by 3 five-minute washes with cold
PBS with 0.1% Triton-X. Cover slips were then mounted on slides for visualization on a Zeiss
fluorescent microscope (Zeiss, Thornwood, NY).

Preparation of Cell Suspensions
Lungs were perfused with sterile PBS by injection into the right ventricle to remove remaining
blood and then placed in PBS containing 20 mg/ml Collagenase A, 2.4 U/ml Dispase II solution,
and 50 μl/ml DNAse (Roche, Indianapolis, IN) for 30 minutes.
The lung tissue was dissociated using the gentleMACS Octo Dissociator (Miltenyi Biotec,
Auburn, CA) and then centrifuged (1100 x g for 10 minutes) to collect the sample material. The
sample was resuspended with PBS and used for magnetic cell separation and flow cytometry.

Flow Cytometry
Antibodies and reagents
ILC1 and ILC2 numbers 4 hours after exposure to nano-TiO2 from lung tissue were determined
by flow cytometry as previously described [8].
CD45+CD161+CD335+,

while

ILC2

were

1+CD25+IL1R1+.
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Briefly, ILC1 were defined as Lin-

defined

as

Lin-CD45+CD90.1+KLRG-

Monoclonal antibodies specific for CD90.1 (FITC), KLRG1 (APC EFLUOR 780), CD25 (APC),
CD161 (PERCP EFLUOR 710), and CD335 (EFLUOR 450) were purchased from eBioscience
(San Diego, CA). Lineage cocktail (Lin; ALEXA FLUOR 700) was used to gate out (CD3, CD14,
CD16, CD19, CD20, and CD56: Biorad, Hercules, CA) CD3 T lymphocytes, CD14 Monocytes,
CD16 NK cells, granulocytes, CD19 B lymphocytes, CD20 B lymphocytes, and CD56 NK cells.
Antibodies for CD45 (Cyanine 5) were from Invitrogen (Carlsbad, CA), while those for IL1R1 (PE)
where from Sino Biologicals (North Wales, PA). Flow cytometry was performed on a FACSAria
(BD Bioscience, Franklin Lakes, NJ). Data were analyzed with FCS Express 6 Software (De Novo
Software, Glendale, CA).

Isolation of Group II Innate Lymphoid Cells
ILC2 were isolated as per manufacturer`s instructions (Miltenyi Biotec, Auburn, CA). Briefly,
lineage-positive cells were indirectly labeled with a cocktail of ALEXA FLUOR 700-conjugated
antibodies, as primary labeling reagent, and antibodies conjugated to MicroBeads were used as
secondary labeling reagents. In the second step, lineage-negative cells were labeled with CD45,
CD90.1, KLRG-1, CD25, and IL1R1, labeled with MicroBeads and isolated by positive selection
from the pre-enriched lineage negative cell-fraction by separation over a MACS Column (Miltenyi
Biotec, Auburn, CA), which was placed in the magnetic field of a MACS Separator. After negative
selection, the cells were subsequently eluted as the positively selected cell fraction containing
ILC2.

Cytokine Analysis of Cell Culture Media and Measurement of Phospho-NF-ĸB
Isolated ILC2s were incubated (37°C, 90% humidity, 5% CO2) overnight in supplemented (10%
fetal bovine serum, 1% penicillin/streptomycin, 1% sodium pyruvate, 1% L-glutamine) Dulbecco`s
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Modified Eagle Medium (Corning, Manassas, VA). The following day, the cell culture medium
and cellular portion were separated via centrifugation (1100 x g for 10 minutes). IL-4, IL-5, and
IL-13 levels were measured in the cell culture medium via multi-spot inflammatory assays per
manufacturer's directions (Meso Scale Diagnostics, Rockville, MD). Lastly, isolated cells were
lysed and phospho-NF-κB (Ser468 and Ser536) was measured (Meso Scale Diagnostics,
Rockville, MD).

Systemic Treatment with anti-Interleukin-33 Antibody
Rats were treated 1 hour prior to pulmonary nano-TiO2 exposure with pharmacological grade
polyclonal anti-IL-33 antibody (CAT#ABF108, EMD Millipore, Temecula, CA: intraperitoneal
1mg/kg). The antibody and dosage were selected based on previous murine studies [22]. The
antibody used was a polyclonal anti-IL-33 antibody developed in the rabbit with specific reactivity
toward mouse IL-33 and expected cross reactivity due to the close homology to rat IL-33. We
determined the interspecies homology of the anti-IL-33 target between rats and mice to be 87%
(Supplementary Figure 1). Plasma, bronchoalveolar lavage fluid, and lung tissue were obtained
4 hours post-exposure from treated animals for measurement of IL-33. Uterine microvascular
assessments were conducted 24 hours after treatment in a separate cohort of animals.

Pressure Myography Microvessel Preparation
After measuring MAP, the uterus was removed and placed in a dissecting dish with physiological
salt solution (PSS) maintained at 4 °C. Radial arterioles were isolated, transferred to a vessel
chamber, cannulated between two glass pipettes, and tied with silk sutures in the chamber (Living
Systems Instrumentation, Burlington, VT). The chamber was superfused with fresh oxygenated
(5% CO2/21% O2) PSS and warmed to 37 °C. Arterioles were pressurized to 60 mm Hg using a
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servo control system and extended to their in situ length. Internal and external arteriolar diameters
were measured using video calipers (Colorado Video, Boulder, CO).

Arteriolar Reactivity
Previous work by our group has shown that ENM exposure impacts endothelium-dependent
dilation most severely within 24 hours, a condition which has been shown to improve but did not
fully return to control levels after 168 hours. Based on these findings, all vascular assessments
for this study were conducted 24 hours post-exposure [42].

Arterioles were allowed to develop spontaneous tone, defined as the degree of constriction
experienced by a blood vessel relative to its maximally dilated state. Vascular tone ranges from
0% (maximally dilated) to 100% (maximal constriction). Vessels with a spontaneous tone ≥ 20%
less than initial tone were included in this study. After equilibration, various parameters of
arteriolar function were analyzed. Vessels that did not develop sufficient spontaneous tone were
not included in the data analysis.

Endothelium-Dependent Dilation— arterioles were exposed to increasing concentrations of
acetyl choline (ACh: 10−9 - 10−4 M) added to the vessel chamber.
Endothelium-Independent Dilation—increasing concentrations of sodium nitroprusside (SNP:
10−9 - 10−4 M) were used to assess arteriolar smooth muscle responsiveness.
Arteriolar Vasoconstriction—arterioles were exposed to increasing concentrations of
phenylephrine (PE: 10 −9 - 10−4 M). The steady state diameter of the vessel was recorded for at
least 2 min after each dose. After each dose curve was completed, the vessel chamber was
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washed to remove excess chemicals by carefully removing the superfusate and replacing it with
fresh warmed oxygenated PSS. After all experimental treatments were complete, the PSS was
replaced with Ca2+-free PSS until maximum passive diameter was established.

Pressure Myography Calculations
Data are expressed as means ± standard error. Spontaneous tone was calculated by the following
equation:

𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠 𝑡𝑜𝑛𝑒 (%) = {

(𝐷𝑚 − 𝐷𝑖)
} 𝑥 100
𝐷𝑖

, where Dm is the maximal diameter and Di is the initial steady state diameter recorded prior to
the experiment. Active responses to pressure were normalized to the maximal diameter using the
following formula:
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 = 𝐷𝑠𝑠/𝐷𝑚
, where Dss is the steady state diameter recorded during each pressure change. The
experimental responses to ACh, PE, and SNP are expressed using the following equation:

𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟 (𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑚𝑎𝑥𝑖𝑚𝑎𝑙 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟) = {

(𝐷𝑠𝑠 − 𝐷𝑐𝑜𝑛)
} 𝑥 100
(𝐷𝑚 − 𝐷𝑐𝑜𝑛)

, where DCon is the control diameter recorded prior to the dose curve, DSS is the steady state
diameter at each dose of the curve. The experimental response to PE is expressed using the
following equation:

𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟 (𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑚𝑎𝑥𝑖𝑚𝑎𝑙 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟) = {
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(𝐷𝑐𝑜𝑛 − 𝐷𝑠𝑠)
} 𝑥 100
(𝐷𝑐𝑜𝑛)

Wall thickness (WT) was calculated from the measurement of both inner (ID) and outer (OD)
steady state arteriolar diameters at the end of the Ca2+ free wash using the following equation:
𝑊𝑇 = (𝑂𝐷 − 𝐼𝐷)/2
Wall-to-lumen ratio (WLR) was calculated using the following equation:
𝑊𝐿𝑅 = 𝑊𝑇/𝐼𝐷

Statistics
Point-to-point differences in the dose response curves were evaluated using two-way repeated
measures analysis of variance (ANOVA) with a Tukey`s post-hoc analysis when significance was
found. The slopes of the dose response curves were determined through a nonlinear regression.
The animal characteristics, vessel characteristics and dose response curve slopes were analyzed
using a one-way ANOVA with a Tukey post-hoc analysis when significance was found. All
statistical analysis was completed with GraphPad Prism 5 (San Diego, CA) and SigmaPlot 11.0
(San Jose, CA). Significance was set at p < 0.05, n is the number of arterioles, and N is the
number of animals.
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Results:
SEM Images and Mass Spectrometry of Nano-TiO2
Figure 1 shows field-emission scanning electron microscope images (Hitachi S4800, Tokyo,
Japan) of the nano-TiO2 suspension used for this study. As seen in Figure 1 A, the suspended
particles present significant agglomeration. Figure 1 B shows the elemental composition of the
nano-TiO2 suspension (Bruker, Billerica, MA), indicating the prevalent presence of titanium.

Animal and Vessel Characteristics
No significant changes were observed in age, mean arterial pressure (MAP), heart rate and body
weight between control and exposure groups (Table 1). Additionally, radial arteriolar inner and
outer diameter, tone, passive diameter, wall thickness, wall to lumen ratio and calculated wall
tension were not affected by nano-TiO2 exposure and treatment with an anti-IL-33 antibody (Table
2). From these results we can infer that acute nano-TiO2 exposure does not alter vascular tone or
the balance of its contributing influences.

Acute Plasma and BALF Cytokine Secretion Patterns Following Pulmonary Nano-TiO2
Exposure
A time-course study was initially performed to identify the temporal effect of nano-TiO2 on cytokine
secretion. Plasma samples were obtained at 0,1,2, and 4 hours following nano-TiO2 exposure by
tail vein puncture. Figure 2 shows the results of the multiplex analysis. No differences existed at
time 0, 1 or 2 hours post-exposure. However, significant differences were detected 4 hours postexposure in plasma levels of the pro-inflammatory cytokines IL-4, IL-5, IL-13, TNF-α, IL-1β, while
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no alterations in the cytokines IFN-γ, KC/GRO, TNF-α, IL-10, IL-6, MCP-1, TIMP-1, Lipocalin-2,
and TSP-1 were noted (Data not shown).

In order to confirm the results observed in the plasma, the cytokine levels in the BALF were also
measured 4 hours post-exposure. Multiplex analysis of the BALF (Figure 3) also showed an
almost 5-fold increase in IL-5 and a 6-fold increase in IL-4, IL-13, TNF-α, and IL-1β, while no
changes were seen in the other cytokines (Data not shown). Based on the collective cytokine
profile associated with this exposure paradigm, the results provide evidence that acute pulmonary
nano-TiO2 exposure may trigger a T-Helper cell type 2 (Th2) response beginning 4 hours postexposure.

IL-33 Secretion by Lung Epithelial Cells Pre- and Post- Exposure and Following
Treatment with an anti-IL-33 Antibody
IL-33 plays a significant role in initiating and modulating lung inflammatory and immunological
responses [19], by inducing the secretion of Th2 pro-inflammatory cytokines. It is constitutively
present in mucosal epithelial cells and acts as a “danger” signal after tissue injury by activating
immune cells. To determine the effect of nano-TiO2 on pulmonary and plasma IL-33 levels,
immunohistochemistry of tracheal sections was conducted 4 hours post-exposure. In a separate
cohort of control and exposed animals, multiplex analysis of plasma and BALF IL-33 was also
performed 4 hours post-exposure. Figure 4 shows representative images of lung sections from
control and exposed rats stained for IL-33 4 hours post-exposure and the quantitative
measurements for both groups.

Relative fluorescence intensity of IL-33 was significantly

increased in exposed animals by 26.8 ± 4.3%, while plasma and BALF levels indicated a 38 ± 2%
and 171 ± 13% increase in IL-33 respectively (Figure 5). Interestingly, treatment 1 hour prior to
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exposure to nano-TiO2 with pharmacological grade polyclonal anti-IL-33 antibody (EMD Millipore,
Temecula, CA: intraperitoneal 1mg/kg) resulted in a decrease in plasma and BALF IL-33 levels 4
hours post-exposure (61 ± 2% in plasma and 150 ± 7% in BALF) when compared to nano-TiO2
exposed and untreated animals. The results herein described provide evidence that reveals the
critical role played by IL-33 in the initiation of the inflammatory response to ENM.

Flow Cytometric Analysis of ILC1 and ILC2
Polarization of T-cells requires several days [21], therefore, the early appearance of Th2 cytokines
in the circulation after nano-TiO2 suggests that other, more rapid immune effector cells may be
involved. Previous work has indicated that both ILC1 and ILC2 [11,14] reside in the lungs and
may be involved in lung inflammatory responses and pathology. Therefore, we next wanted to
determine the effect of nano-TiO2 exposure on ILC1 and ILC2 levels in the lungs. For this reason,
multi-parametric flow cytometric analysis was conducted on lung tissue from control and nanoTiO2 exposed Sprague-Dawley rats for ILC1 (Data not shown) and ILC2 (Figure 6) 4 hours postexposure. No significant differences were noted in ILC1 levels pre- and post- exposure while ILC2
levels increased from 0.2 ± 0.2% to 2 ± 0.2% (Figure 7 A and B).

NF-ĸB Phosphorylation and Th2 Cytokine Secretion by Isolated ILC2
Activation of the NF-κB pathway has been shown to play a role in inflammation through its ability
to induce the transcription of proinflammatory genes [33,34]. Specifically, phosphorylation of NF—
ĸB at both serine residues 468 and 536 are associated with inflammatory response [33,34].
Therefore, levels of phospho- NF—ĸB were measured in isolated ILC2 from control and nanoTiO2 exposed animals (Figure 8). No significant differences were noted in phosphorylation of the
Serine-536 residue between the 2 groups, while phosphorylation of Serine-468 was increased
after acute pulmonary nano-TiO2 exposure (129 ± 7% of control levels).

100

Lastly, isolated ILC2 were cultured overnight and IL-4, IL-5 and IL-13 levels in the cell-culture
media were measured. Nano-TiO2 resulted in a significant increase in IL-4, IL-5, and IL-13 (122
± 7%, 141 ± 9%, 159 ± 8% of control levels respectively) (Figure 9).

Effect of Acute Pulmonary Nano-TiO2 Exposure and Systemic Immunotherapy on Uterine
Radial Arterioles
Endothelium-Dependent Dilation
In order to identify the acute reproductive effects associated with nano-TiO2 exposure, radial
arterioles were isolated from the uterus of control and exposed animals 24 hours post-exposure
and endothelium-dependent and independent dilation along with adrenergic sensitivity were
tested. Previous work by our group has shown that ENM exposure impacts vascular reactivity
most severely within 24 hours, a condition which has been shown to improve but not fully return
to control levels after 168 hours [42]. Based on these findings, all vascular assessments for this
study were conducted 24 hours post-exposure.

Endothelium-dependent dilation of radial arterioles was significantly impaired following
intratracheal instillation of 100 µg of nano-TiO2 (Figure 10), with a mean decrease in dilation of
49 ± 7% compared to controls and 24 ± 10% compared to anti-IL-33 antibody-treated rats. These
results suggest that pulmonary nano-TiO2 exposure disrupts normal physiological vascular
endothelial function and that pre-treatment with an anti-IL-33 antibody partially attenuates the
systemic acute inflammatory cascade triggered by lung-derived IL-33.
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In contrast to endothelium-dependent relaxation, no point to point differences were seen in αadrenergic and endothelium-independent dilation between control, nano-TiO2 exposed, and
treated groups (Data not shown).
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Discussion:
The inflammatory paradigm tested herein has been suggested by previous studies [18,36,58].
While these studies explored pulmonary responses to exogenously administered IL-33, carbon
nanotubes and viral infection, our findings provide additional evidence of a similar link between
acute pulmonary ENM exposure and subsequent inflammatory mechanisms with systemic
microvascular consequences. Perhaps the most important finding of this study is the identification
of IL-33 as a potential contributor to the systemic inflammatory phenotype and microvascular
dysfunction resulting from acute pulmonary ENM exposure.

We hypothesized that the innate response to pulmonary nano-TiO2 exposure is triggered by the
secretion of IL-33 by lung epithelial cells. IL-33, a member of the IL-1 family, plays a significant
role in initiating and modulating lung inflammatory and immunological responses [27], by inducing
the secretion of Th2 pro-inflammatory cytokines through the Suppression of Tumorigenicity 2
(ST2) receptor in a variety of immune cells [59]. Previous studies have shown that exposure to
multi-walled carbon nanotubes triggers the IL-33/ST2 axis leading to the activation of mast-cells
and macrophages [4]. Interestingly, IL-33 is also required for the maturation, activation and egress
of ILC2 lineage cells from the bone marrow to specific target organs [46]. Several previous studies
by our group and others have extensively investigated the cardiovascular effects of pulmonary
ENM exposure [1,30]. These studies consistently reveal that nano-TiO2 exposure increases
leukocyte activation [38], proinflammatory mediators [41], and oxidative stress [20]. Collectively,
this results in endothelium-dependent dysfunction. ILCs are a recently identified subpopulation of
immune effector cells [27,39]. They are critical, non-cytolytic tissue-resident cells that can be
activated and respond acutely to danger signals or “alarmins” such as IL-33 from mucosal tissue
by producing a distinctive array of cytokines to maintain mucosal integrity. Group II ILCs
specifically, secrete the cytokines IL-5, IL-13, IL-9, amphiregulin, and low quantities of IL-4 [36]
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and have been linked to several lung-associated conditions including pathogen infections (viruses
and helminths), asthma, and pulmonary fibrosis [13]. Lung ILC2 have an important role in
regulating tissue remodeling and repair during acute epithelial injury and asthma [28]. Considered
together, it is reasonable to speculate that the IL-33/ILC2 axis may impact systemic microvascular
function after pulmonary ENM exposure.

Perhaps, the most significant finding of this study is the identification of a potential role for IL-33
in the initiation of an acute inflammatory response and the effects on systemic microvascular
dysfunction (Figure 10). This was achieved by interrupting the IL-33/ST2 signaling axis with an
anti-IL-33 antibody treatment prior to ENM exposure. In these experiments, the control group (IT
saline) did not receive the anti-IL-33 antibody. The scientific rationale for this decision was that
the technique (isolated, perfused and pressurized arterioles) used to assess microvascular
dysfunction is a plasma free system. As such, it was impossible to assess the role of the complete
IL-33/ST2 axis on arteriolar tone and/or reactivity. Whereas, this approach directly measured the
impact that IL-33 inflammatory signaling has on microvascular function. It remains a distinct
possibility that the IL-33/ST2 axis activated by pulmonary ENM exposure directly influences
microvascular tone and/or reactivity. IL-33 expression has been identified in human vascular
endothelial cells; whereas, is absent in murine vascular tissue [32]. This supports our postulate
that IL-33 is impacting microvascular function via inflammation, rather than a direct activation of
the ST2 receptor. Future in vivo studies must directly assess the impact of circulating IL-33 on
microvascular tone, reactivity and blood flow.

While our study provides plausible mechanistic insights into both the inflammatory and
microvascular effects associated with ENM exposure, additional considerations as well as the
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limitations must be kept in mind. ENM exposure has been shown to affect other innate immune
effector cells such as neutrophils [35], macrophages [5,48], and dendritic cells [23]. Therefore,
other mechanisms including local generation of reactive of oxygen species, secretion of
chemokines and prostaglandins by macrophages and stimulation of the adaptive immune system
by antigen-presenting cells may play a role in the systemic inflammatory response and vascular
effects seen in this study. It is also worth noting that in this study an immune response associated
with pulmonary ENM exposure was observed as early as 4 hours post-exposure, as evidenced
not only by an increase in the proportion of lung-resident ILC2s (Figure 7), but also by augmented
levels of the Th2 cytokines IL-4, IL-5, and IL-13 (Figures 2 and 3). This response timeframe is in
agreement with previous studies, that have reported IL33, ILC2 numbers as well as lung and
serum Th2 cytokines increase within 6-12 hours of lung injury [50, 51]. Furthermore, isolated
ILC2s have been shown to respond dose-dependently to transient or continuous stimulation with
IL-2 and/or IL-33 within 3 hours [52]. Similarly, nano-TiO2 instillation at lung burdens of 40-160
µg/rat has also been shown to increase BALF inflammatory mediators within 4 hours of exposure
[53]. We report herein a similar phenomenon as the lung burden used in this study was
comparable at 100 µg/rat.

Our findings contribute consistent evidence for a role of ILC2s in the acute pulmonary response
to ENM exposure. Due to the inherent limitations associated with our experimental in vivo model,
we were unable to directly establish causality. In order to directly confirm such an observation,
ILC2 deletion would be necessary. Our research program has a long-standing interest in the
systemic microvascular consequences of pulmonary particle exposure. Rat models are primarily
used in our in vivo studies as they are the most appropriate and widely used animals for
microvascular research. However, they are not commonly or easily adapted for transgenic
studies. As such, an ILC2 rat deletion model does not exist. If such a model were created in the
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future, it would then be possible to directly confirm a causative relationship between ENM
exposure and ILC2 activation, proliferation and recruitment.

Lastly, to allow periodic blood sampling for cytokine analysis, intratracheal instillation was chosen
as the preferred exposure method. The above-mentioned dose of nano-TiO2 was selected based
on previous studies conducted by our group which have shown that it is associated with significant
microvascular impairment, oxidative and nitrosative stress and alveolar macrophage recruitment
[36, 54]. Additionally, to better understand the relevance of the exposure paradigm used in this
study to humans, alveolar surface areas must be known [47]. The rat alveolar surface area is 0.4
m2/lung. Therefore, the rat burden of 50 μg/lung would result in 125 μg/m2. Given that the human
alveolar surface area is 102 m2, the equivalent human burden of this exposure paradigm would
be 12.75 mg. The next logical question is: How long would it take to achieve this burden in
humans? In this regard, lung burden may be calculated as:
nano-TiO2 aerosol concentration  minute ventilation  exposure duration  deposition fraction,
with the following values:
25.5 mg = nano-TiO2 aerosol concentration  7600 ml/min  (8 hr/day  60 min/hr)  14%,
and therefore:
25.5 mg = nano-TiO2 aerosol concentration  0.5 m3/day.
Considering both the National Institute for Occupational Safety and Health (NIOSH) and the
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (0.3 mg/m3
and 5 mg/m3 respectively) [43], it would require 0.34 working years or 122 working days for a
human to achieve similar exposure levels to those used in this study.
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In conclusion, the current study provides novel evidence that links acute pulmonary ENM
exposure and systemic microvascular effects. Because this inflammatory link exists between the
lung and the uterine microcirculation, it remains to be determined if such an axis extends to the
placenta and or fetus.
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Figure Legends:

Figure 1. Characterization of Nano-TiO2. (A) SEM image and (B) Energy dispersive
spectroscopy showing elemental composition of the nano-TiO2 suspension used in this study.

Figure 2. Nano-TiO2 exposure increases T-Helper type II cytokines 4 hours post-exposure.
Multiplex cytokine analysis showing concentrations of (A) IL-4, (B) IL-1β, (C) TNF-α, (D) IL-5, and
(E) IL-13. Serum samples were obtained at 0, 1, 2 and 4 hours post-exposure via tail-vein
puncture (N=6). Statistics were analyzed with two-way ANOVA (P ≤ 0.05), * Sham control group
vs. nano-TiO2 exposed groups.

Figure 3. Nano-TiO2 exposure also increases T-Helper type II cytokines 4 hours postexposure in bronchoalveolar lavage fluid (BALF). Multiplex cytokine analysis showing
concentrations of IL-4, IL-5, IL-13 in BALF from exposed and control animals 4 hours postexposure (N=6). Statistics were analyzed with two-way ANOVA (P ≤ 0.05), * Sham control group
vs. nano-TiO2 exposed groups.

Figure 4. Nano-TiO2 exposure is associated with an increase in pulmonary interleukin-33
levels. Lung sections from control (A) and nano-TiO2 exposed (B) animals obtained 4 hours postexposure were stained for interleukin-33. Fluorescence was achieved by staining tracheal
sections with an anti-IL-33-FITC conjugated antibody. Relative fluorescence is shown in (C)
tagged antibody (N=6-7). Statistics were analyzed with two-way ANOVA (P ≤ 0.05), * Sham
control group vs. nano-TiO2 exposed groups.

Figure 5. Pre-treatment of nano-TiO2 – exposed animals with an anti-IL-33 antibody lowers
BALF and plasma IL-33. Interleukin-33 levels in (A) BALF and (B) plasma in control, nano-TiO2
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exposed groups and in rats pre-treated with an anti-IL-33 antibody. Rats were pre-treated with an
anti-IL-33 antibody (1 mg/kg) 30 minutes prior to exposure. Plasma and BALF IL-33 levels were
measured 4 hours post-exposure. Statistics were analyzed with two-way ANOVA (P ≤ 0.05). *
Sham control group vs. nano-TiO2 exposed groups, Ŧ P<0.05 Exposed + Anti-IL-33 Antibody vs
Exposed.

Figure 6. Flow cytometric analysis of lung-resident Group II innate lymphoid cells. Flow
cytometry of lung tissue 4 hours post-exposure for Group II Innate Lymphoid Cells in (A) control
and (B) nano-TiO2 exposed animals (N=6).

Figure 7. Nano-TiO2 exposure increases pulmonary ILC2 but not ILC1. Quantification of
percentage of total pulmonary cells of (A) ILC1 and (B) ILC2 in control and nano-TiO2 exposed
animals (N=6). Statistics were analyzed with two-way ANOVA (P ≤ 0.05), * Sham control group
vs. nano-TiO2 exposed groups.

Figure 8. Nano-TiO2 exposure increases NF-ĸB phosphorylation at Serine-468 in isolated
ILC2. Quantification of NF-ĸB phosphorylation at (A) serine-468 and (B) serine 536 in isolated
ILC2 from control and nano-TiO2 exposed animals (N=6). Statistics were analyzed with two-way
ANOVA (P ≤ 0.05), * Sham control group vs. nano-TiO2 exposed groups.

Figure 9. Th2 cytokine secretion in isolated ILC2 is increased by nano-TiO2 exposure.
Multiplex cytokine analysis showing concentrations of IL-4, IL-5, IL-13 supernatant from isolated
ILC2 cultured overnight from control and nano-TiO2 exposed animals (N=6). Statistics were
analyzed with two-way ANOVA (P ≤ 0.05), * Sham control group vs. nano-TiO2 exposed groups.
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Figure 10. Endothelium-dependent dilation of radial arterioles is blunted by nano-TiO2
exposure and improved by pre-treatment with an anti-IL-33 antibody. Endotheliumdependent dilation of uterine radial arterioles from control, exposed and anti-IL-33 antibody
treated animals was determined using pressure myography (n = 12-18). All vascular assessments
were performed 24 hours post-exposure.

Statistics were analyzed with two-way ANOVA (P ≤

0.05). * Sham control group vs. nano-TiO2 exposed groups, Ŧ P<0.05 Exposed + Anti-IL-33
Antibody vs Exposed.
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Abstract:
The fetal consequences of gestational engineered nanomaterial (ENM) exposure are unclear.
The placenta is a barrier protecting the fetus and allowing transfer of substances from the
maternal circulation. The purpose of this study was to determine the effects of maternal pulmonary
titanium dioxide nanoparticle (nano-TiO2) exposure on the placenta and umbilical vascular
reactivity. We hypothesized that pulmonary nano-TiO2 inhalation exposure increases placental
vascular resistance and impairs umbilical vascular responsiveness. Pregnant Sprague-Dawley
rats were exposed via whole-body inhalation to nano-TiO2 with an aerodynamic diameter of 188
± 0.4 nm. On gestational day (GD) 11, rats began inhalation exposures (6h/exposure). Daily lung
deposition was 88 ± 3 μg. Animals were exposed for 6 days for a cumulative lung burden of
525 ± 16 μg. On GD 20 placentas, umbilical artery and vein were isolated, cannulated, and treated
with acetylcholine (ACh), angiotensin II (ANGII), S-Nitroso-N-acetyl-DL-penicillamine (SNAP), or
calcium-free superfusate (Ca2+-free). Mean outflow pressure was measured in isolated placental
units. ACh increased mean outflow pressures to 53 ± 5 mm Hg in sham-controls but only to 35 ± 4
mm Hg in exposed subjects. ANGII decreased outflow pressure in placentas from exposed
animals (17 ± 7 mm Hg) compared to sham-controls (31 ± 6 mm Hg). Ca2+-free superfusate
yielded maximal outflow pressures in sham-control (63 ± 5 mm Hg) and exposed (30 ± 10 mm Hg)
rats. Umbilical artery endothelium-dependent dilation was decreased in nano-TiO2 exposed
fetuses (30 ± 9%) compared to sham-controls (58 ± 6%), but ANGII sensitivity was increased (79 ± 20% vs -36 ± 10%). These results indicate that maternal gestational pulmonary nano-TiO2
exposure increases placental vascular resistance and impairs umbilical vascular reactivity.
Keywords: engineered nanomaterials, titanium dioxide nanoparticles, microcirculation, placenta
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Introduction:
While the field of nanotechnology has seen a tremendous expansion and growth in recent years
[20], a more complete understanding of maternal and fetal effects associated with ENM exposure
warrants further investigation and is of key relevance for the safe design and regulation of
industrially relevant nanomaterials. Pregnancy represents a sensitive window and is
characterized by profound adaptive physiological changes [18], particularly of the maternal-fetal
circulation. These changes include vasculogenesis, the de novo formation of blood vessels by
endothelial progenitor cells and angiogenesis, the development of new vessels from pre-existing
ones. All these mechanisms cause an increase in overall vascular diameter and number which
results in a significant reduction in the vascular resistance of the maternal-fetal circulation.
Expansive remodeling of the maternal circulation is a crucial and fundamental process for a
successful pregnancy and any impairment in this finely regulated series of events may have
catastrophic effects on maternal and fetal health. Indeed, insufficient growth and development of
the uteroplacental circulation results in placental under-perfusion and has been associated with
intrauterine growth restriction (IUGR) [13] and pre-eclampsia [7].

The study of developmental and reproductive effects of ENM in various animal models has in
recent years gained more attention [4,12]. We have reported that in rats, inhalation of 11.3 mg/m3
of nano-TiO2 during late gestation resulted in an impairment in endothelium-dependent reactivity
of fetal vessels, while offspring survival was severely comprised by inhalation of a higher dose for
11 days [25]. Similarly, inhalation of 10.6 mg/m3 nano-TiO2 during late gestation (average 6.8
days, 5 h/day) was associated with an impairment of endothelium-dependent dilation and active
mechano-transduction in uterine arteries and a reduction in maximal mitochondrial respiration in
female offspring [24]. Additionally, reduced pup weight and litter size [2] along with persistent
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cognitive deficits of gestationally exposed young adult rats have also been reported [5], thus
highlighting the potential transgenerational impact of gestational ENM exposure.

One of the critical components of the maternal-fetal vascular axis is the placenta. The placenta is
a transient barrier organ with significant functions that are crucial for fetal development. The
placental cellular barrier at the maternal-fetal interface consists of trophoblasts and endothelial
cells [11]. Between these two cell layers, the surrounding tissue is formed primarily by stromal
fibroblasts and macrophages (Hofbauer cells). The importance of the placenta is underscored by
its role in the fetal regulation of gas and heat transfer, excretion, metabolism, synthesis and
secretion of endocrine hormones, hematopoiesis and immunity [11]. Additionally, the placenta
maintains the balance between the hydrostatic and oncotic pressures in the capillary
microcirculation and the interstitial fluid. At full term, the placenta receives >90% of uterine blood
flow as a result of significant hemodynamic adaptations occurring primarily due to a significant
decrease in vascular resistance caused by extensive remodeling of the maternal uterine
microvasculature, a decrease in vascular tone and an increase in the vasodilatory sensitivity of
the maternal-fetal circulations [18].

Since the development of nanotechnology, the question of maternal-fetal particle translocation
has been present. In vitro, fluorescently labelled carboxylate-modified polystyrene beads with a
diameter of up to 500 nm have been shown to cross the placental barrier and induce trophoblast
apoptosis [10]. Silica nanoparticles having a diameter of less than 100 nm and nano-TiO2 with a
diameter of approximately 35 nm have been shown to cross the placental barriers, potentially
resulting in impaired placental function by decreasing the area of the trophoblasts and the length
of the villi in the labyrinthine layer of the placenta [9].
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The contribution of placental and maternal-fetal vascular dysfunction in the developmental origin
of disease and health cannot be over-emphasized. Yet, there is a paucity of in-vivo data regarding
the effects of pulmonary ENM exposure on placental vascular resistance because it is essentially
impossible to directly assess these variables. Therefore, the purpose of this study was to
determine ex-vivo the effects of nano-TiO2 exposure on placental hemodynamics and on the
function of the umbilical vasculature. We hypothesized that maternal pulmonary nano-TiO2
exposure results in a significant increase in placental vascular resistance and an impairment in
umbilical vascular reactivity. We adopted and modified an established ex-vivo perfusion placental
model [6] to make direct assessments of placental outflow pressure and placental flow rate
measured as a function of the inflow pressure. Vascular reactivity of the umbilical artery and vein
were directly assessed via pressure myography.

134

Methods:
Nanomaterial Characterization
Nano-TiO2 P25 powder, obtained from Evonik (Aeroxide TiO2, Parsippany, NJ), has previously
been shown to be a mixture composed primarily of anatase (80%) and rutile (20%) TiO 2, with a
primary particle size of 21 nm and a surface area of 48.08 m2/g, and a Zeta-potential of -56.6 mV
[26]. Analysis of the elemental composition of the nano-TiO2 was conducted via energy dispersive
spectroscopy.

Scanning and transmission electron microscopy (SEM) procedures were performed using a nanoTiO2 exposed 0.2 um polycarbonate filter with a 200 mesh formvar coated copper grid affixed in
the center. A wedge-shaped portion of the polycarbonate filter was mounted onto a 13 mm
aluminum stub using carbon double stick tape. The sample was sputter coated with goldpalladium for two minutes. The sample was imaged at 5 KeV using a Hitachi S4800 field-emission
scanning electron microscope (Tokyo, Japan). For transmission electron microscopy, the
exposed grid was removed from the polycarbonate filter, and imaged at 80 KeV on a JEOL 1400
transmission electron microscope (Tokyo, Japan).

Experimental Animals and Whole-Body Inhalation Exposure
Female Sprague – Dawley rats (8-10 weeks) were purchased from Hilltop Laboratories
(Scottdale, PA) and housed in an AAALAC approved facility at West Virginia University (WVU)
with 12:12 h light – dark cycle and regulated temperature. Rats were allowed ad libitum access
to food and water. All procedures were approved by the Institutional Animal Care and Use
Committee of WVU.
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Nano-TiO2 aerosols were generated using a customized high-pressure acoustical generator
(HPAG) and then allowed to enter the whole-body exposure chamber. A personal DataRAM
(pDR-1500; Thermo Environmental Instruments Inc., Franklin, MA) was utilized to sample the
exposure chamber air to determine the average mass concentration in real-time. Feedback loops
within the software automatically adjusted the acoustic energy to maintain a stable mass
concentration during the exposure. A target DataRAM concentration of 10 mg/m3 for a period of
6 hours was selected as previously described [26]. A concurrent gravimetric measurement
indicated an average mass concentration of approximately 10 mg/m3 during the 6 hour exposure
period. Aerosol size distributions were examined from the exposure chamber with: 1) a highresolution electrical low-pressure impactor (ELPI+; Dekati, Tampere, Finland), (2) a scanning
particle mobility sizer (SMPS 3938; TSI Inc., St. Paul, MN), and (3) an aerodynamic particle sizer
(APS 3321; TSI Inc., St. Paul, MN). Bedding material soaked with water was used in the exposure
chamber to maintain a comfortable humidity during the exposure. Sham-control animals were
exposed to HEPA filtered air only with similar chamber conditions in terms of temperature and
humidity.

To allow for normal implantation and neovascularization, inhalation exposures were initiated on
GD 11 and lasted for 6 days. Exposure days were not consecutive to decrease animal stress.
Once the steady state nano-TiO2 aerosol concentration was achieved, the exposure duration was
adjusted to produce a daily calculated lung deposition of 31 ± 1.1 μg per day, and the cumulative,
calculated dose was therefore 217 ± 1.0 μg. Lung deposition was calculated based on previously
described mouse methodology, and normalized to rat weight and to pregnant rat minute
ventilation using the equation: D = F⋅V⋅C⋅T, where F is the deposition fraction (14%), V is the
minute ventilation based on body weight, C equals the mass concentration (mg/m3), and T equals
the exposure duration (minutes) [31]. The target concentration was 10 mg/m3 and the duration
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was 4-6 h/exposure (depending on the steady state concentration, as this was used to calculate
the lung burden). The last exposure was conducted 24 h prior to sacrifice and experimentation.
Control animals were exposed to HEPA filtered air only.

Collection and Ex Vivo Perfusion of the Rat Placenta
Rats were anesthetized with isoflurane gas (5% induction, 2–3.5% maintenance). The animals
were placed on a heating pad to maintain a 37° C rectal temperature. The trachea was intubated
to ensure an open airway and the right carotid artery was cannulated to allow blood pressure
measurements and sampling. Following blood sampling, the abdominal cavity of the animal was
opened and the uterine horns were externalized. A placenta with a large and intact portion of the
uterine artery was selected, excised and placed in a dissecting dish containing PSS at 4° C. The
amniotic sac was subsequently opened and the placenta was separated from the fetus. The
vitelline artery was removed from the umbilical cord which was severed as close as possible to
the fetus, preserving the umbilical vasculature for cannulation. The maternal circulation was then
tied off using 9-0 silk sutures (Living Systems Instrumentation, Burlington, VT). After separation
of the umbilical artery and vein, the placenta was then transferred to an isolated microvessel
chamber (Living Systems Instrumentation, Burlington, VT).

Both the umbilical artery and vein were cannulated between two glass pipettes (Outer diameter:
175-200 µm, Living Systems Instrumentation, Burlington, VT), and tied with 9-0 silk sutures in the
chamber. The placenta was perfused with PSS and the chamber was superfused with fresh
oxygenated (21% O2/5% CO2) PSS and warmed to 37° C. After a 30-minute equilibration period,
the inflow pressure was increased in a stepwise fashion (0 mm Hg, 20 mm Hg, 40 mm Hg, 60
mm Hg and 80 mm Hg). Outflow pressure and flow rate were measured in placentas in normal
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superfusate and following pre-treatment with acetylcholine (ACh:10-2), S-Nitroso-N-acetyl-DLpenicillamine (SNAP: 10-2), angiotensin II (ANGII: 10-2) and calcium-free superfusate.

Immunohistochemical Staining of Placental Tissue
Uteri from Sham controls and nano-TiO2 exposed animals were removed immediately after
sacrifice and two placentas per rat (n = 3) were dissected away from the pup and the uterine wall.
The placental tissue was immediately placed into a fixative (4% paraformaldehyde) for 3 hours at
4° C and then transferred to PBS overnight. Twelve hours later, the tissue was flash frozen and
stored at -80° C until sectioned. Placentas were sectioned at 50 µm through the center of the
placenta. On day 1 of the protocol, the sections were washed 4 × 5 minutes in 0.1 M PBS to
remove excess cryoprotectant and washed overnight at 4° C. The next day, the sections were
washed 4 × 5 minutes in PBS, placed in 1% H2O2 for 10 minutes and subsequently washed 4 ×
5 minutes in PBS. The tissue was then incubated for at least 1 hour in a blocking solution
containing PBS, 20% Triton X-100 (PBSTX) (Sigma-Aldrich, St Louis, MO, USA) and 20% normal
goat serum (NGS) (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) in PBS.
Tissue sections were placed in a solution containing rabbit anti-Von Willebrand factor (vWFcatalogue number ab6994; dilution 1:2 000; AbCam, Cambridge, MA) in PBSTX and 4% NGS for
16 hours. After incubation with the primary antibody, sections were incubated in a solution
containing biotinylated goat anti-rabbit IgG and a solution containing avidin-biotin horseradishperoxidase conjugate (Vectastain Elite ABC; dilution 1:600; Vector Laboratories) for 1 hour.
Sections were then washed and incubated for 10 minutes in biotinylated tyramine (TSA) (dilution
1:250; Perkin Elmer, Waltham, MA, USA) in PBS containing 3% H2O2 per 1 mL of solution. After
washing, sections were incubated in a solution containing DyLight green 488-streptavidin (1:200,
Fisher Scientific) for 1 hour followed by washes and incubation in PBSTX and 4% NGS for at least
1 hour. Sections were incubated in mouse anti-smooth muscle actin (SMA-catalogue number ab
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7817; dilution 1:1000; AbCam, Cambridge, MA) in PBSTX and 4% NGS for 16 hours. The next
day, sections were incubated in Alexa555 goat anti-rabbit (dilution 1:200; Life Technologies,
Carlsbad, CA, USA) for 1 hour, washed, mounted on Superfrost slides (Fisher Scientific), covered
with a coverslip using ProLong Diamond Antifade Mountant with DAPI (Thermo Fisher, Waltham,
MA) and stored in the dark at 4° C until analysis.

Pressure Myography Vessel Preparation
A placental unit was placed in a dissecting dish with PSS maintained at 4° C. The umbilical cord
was cut longitudinally to reveal the artery and vein. The umbilical artery and vein were isolated,
transferred to a vessel chamber, cannulated between two glass pipettes, and tied with silk sutures
in the chamber (Living Systems Instrumentation, Burlington, VT). The chamber was superfused
with fresh oxygenated (21% O2/5% CO2) PSS and warmed to 37° C. Both vessels were
pressurized to 60 mm Hg using a servo control system and extended to their in-situ length. Internal
and external vascular diameters were measured using video calipers (Colorado Video, Boulder,
CO).

Vascular Reactivity
Vessels were allowed to develop spontaneous tone, defined as the degree of constriction
experienced by a blood vessel relative to its maximally dilated state. Vascular tone ranges from
0% (maximally dilated) to 100% (maximal constriction). After equilibration, various parameters of
vascular function were analyzed.
Endothelium-Dependent Dilation— vessels were exposed to increasing concentrations of ACh
(10−9 - 10−4 M) added to the vessel chamber.
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Endothelium-Independent Dilation—increasing concentrations of SNAP (10−9 - 10−4 M) were
used to assess vascular smooth muscle responsiveness.

Vasoconstriction— vessels were exposed to increasing concentrations of ANGII (10 −9 - 10−4 M).
The steady state diameter of the vessel was recorded for at least 2 min after each dose. After
each dose curve was completed, the vessel chamber was washed to remove excess chemicals
by carefully removing the superfusate and replacing it with fresh warmed oxygenated PSS. After
all experimental treatments were complete, the PSS was replaced with Ca2+-free PSS until
maximum passive diameter was established.

Pressure Myography Calculations
Data are expressed as means ± standard error. Spontaneous tone was calculated by the following
equation:

𝑆𝑝𝑜𝑛𝑡𝑎𝑛𝑒𝑜𝑢𝑠 𝑡𝑜𝑛𝑒 (%) = {

(𝐷𝑚 − 𝐷𝑖)
} 𝑥 100
𝐷𝑖

, where Dm is the maximal diameter and Di is the initial steady state diameter recorded prior to
the experiment. Active responses to pressure were normalized to the maximal diameter using the
following formula:
𝑁𝑜𝑟𝑚𝑎𝑙𝑖𝑧𝑒𝑑 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 = 𝐷𝑠𝑠/𝐷𝑚
, where Dss is the steady state diameter recorded during each pressure change. The
experimental responses to ACh, PE, and SNP are expressed using the following equation:

𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟 (𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑚𝑎𝑥𝑖𝑚𝑎𝑙 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟) = {
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(𝐷𝑠𝑠 − 𝐷𝑐𝑜𝑛)
} 𝑥 100
(𝐷𝑚 − 𝐷𝑐𝑜𝑛)

, where DCon is the control diameter recorded prior to the dose curve, DSS is the steady state
diameter at each dose of the curve. The experimental response to PE is expressed using the
following equation:

𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟 (𝑝𝑒𝑟𝑐𝑒𝑛𝑡 𝑚𝑎𝑥𝑖𝑚𝑎𝑙 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟) = {

(𝐷𝑐𝑜𝑛 − 𝐷𝑠𝑠)
} 𝑥 100
(𝐷𝑐𝑜𝑛)

Wall thickness (WT) was calculated from the measurement of both inner (ID) and outer (OD)
steady state diameters at the end of the Ca2+ free wash using the following equation:
𝑊𝑇 = (𝑂𝐷 − 𝐼𝐷)/2
Wall-to-lumen ratio (WLR) was calculated using the following equation:
𝑊𝐿𝑅 = 𝑊𝑇/𝐼𝐷

Statistics
Point-to-point differences in the dose response curves of the umbilical vessels were evaluated
using two-way repeated measures analysis of variance (ANOVA) with a Tukey`s post-hoc
analysis when significance was found. The animal characteristics and vessel characteristics were
analyzed using a one-way ANOVA with a Tukey post-hoc analysis when significance was found.
A mixed-effects analysis was used to determine the effect of exposure on placental outflow
pressure (GraphPad Prism; San Diego, CA). Wherever sphericity (equal variance) was not met,
the Greenhouse-Geiger correction was adopted. A mix-model linear regression was also
performed to determine the differences in the slopes between the sham-control and nano-TiO2
exposed groups. Significance was set at p < 0.05, n is the number of vessels and placentas, while
N is the number of animals.
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Results
SEM Images and Mass Spectrometry of Nano-TiO2
Figure 1 A shows field-emission scanning electron microscope images (Hitachi S4800, Tokyo,
Japan) of the nano-TiO2 suspension used for this study. The SMPS and APS data were combined
to determine the Geometric Count Median Diameter using the log normal distribution obtained
with the log probability plot method and was determined to be 190 nm with a standard error of 0.5
(Figure 1 B). The ELPI High Resolution data indicated a Geometric Count Median Diameter of
188 nm with a standard error of the mean of 0.4 (Figure 1 C). The aerosol concentration of nanoTiO2 was determined to be 10 ± 0.1 mg/m3 (Figure 1 D).

Animal and Vessel Characteristics
No significant changes were observed in the age, body weight or number of pups between control
and exposure groups (Table 1). Additionally, umbilical artery and vein inner and outer diameter,
tone, wall thickness, wall to lumen ratio and calculated wall tension were not affected by nanoTiO2 inhalation (Tables 2 and 3). Interestingly, the umbilical vein passive inner diameter was
significantly increased in the maternal nano-TiO2 exposed group (623 ± 40 µm) compared to the
sham-control group (543 ± 29 µm). From these results we can infer that maternal nano-TiO2
inhalation may potentially alter vascular wall anatomy in the umbilical macrocirculation.

Ex Vivo Perfusion of the Rat Placenta
Figure 2 A displays a representative ex vivo perfused placenta preparation. An intact placenta
(3) was cannulated between 2 glass pipets via the umbilical artery (1) and the umbilical vein (2).
The input (arterial) perfusion pressure was held constant (0-80 mm Hg) while vasoactive stimuli
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were added. Output pressure and flow rate (µL/min) were the dependent variable representing
placental resistance. Vascular diameter was also measured with video calipers. Figure 2 B shows
a representative image of the traces obtained using the ex vivo perfused placenta preparation.
Panel 1 shows the inflow pressure via the umbilical artery (independent variable), while panels 2
and 3 show the outflow pressure and the perfusate placental flow rate (dependent variables).
Outflow pressure is the result of placental vascular resistance, while placental perfusate flow is a
function of the pressure differential between the umbilical artery and the umbilical vein. No
differences were noted in the placental perfusion flow rate at baseline and following treatment
with the different vasoactive agents (data not shown).

The outflow pressures in the sham-control and maternal nano-TiO2 exposed placentas were
compared. In the normal superfusate, the sham-control placentas displayed a significantly higher
outflow pressure compared to those from exposed dams when the inflow pressure was increased
in a stepwise fashion (Figure 3 A). These results confirm that gestational nano-TiO2 exposure
increases placental vascular resistance. Similarly, sham-control placentas displayed higher mean
outflow pressures after treatment with ACh compared to nano-TiO2 exposed placentas (Figure 3
B), indicating that the observed increase in placental vascular resistance may be due to an
impairment of endothelium-dependent dilation. Figure 4 A and 4 B show that pulmonary
gestational nano-TiO2 exposure did not affect placental endothelial-independent dilation, while
ANGII sensitivity was significantly augmented. Placentas were then treated with calcium-free
superfusate (Figure 5) to measure maximum vascular dilation. In this case, placentas from nanoTiO2 exposed dams presented a significantly decreased output pressure compared to the shamcontrol group. Lastly, Figure 6 shows the mean outflow pressure at 80 mm Hg before and
following treatment with different vasoactive agents. The mean outflow pressure in pre-treated
sham-control placentas was 43 ± 1 mm Hg, while those from exposed animals were 32 ± 3 mm
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Hg. ACh-treated placentas presented mean outflow pressures of 53 ± 5 mm Hg in sham-controls
and 35 ± 4 mm Hg in exposed subjects. SNAP treatment led to mean outflow pressures of 42 ± 8
in sham-controls and 32 ± 9 in nano-TiO2 mm Hg. Treatment with ANGII resulted in a significantly
decreased outflow pressure in the placentas from exposed animals (17 ± 7 mm Hg) compared to
sham-control placentas (31 ± 6 mm Hg). Lastly, calcium-free superfusate yielded outflow
pressures in sham-control and exposed rats of 63 ± 5 mm Hg and 29 ± 10 mm Hg respectively.
Linear regression was used to further confirm that these slopes and therefore the physiologic
continuum of the pressure-flow responses were significantly different between the sham-control
and exposed groups (Supplementary Figures 1-3).

Endothelium-Dependent Dilation
Endothelium-dependent dilation of the umbilical artery was significantly impaired following nanoTiO2 exposure (Figure 7 A), with a mean dilation of 30 ± 9% compared to controls (58 ± 6%). On
the other hand, umbilical vein endothelium-dependent dilation (Figure 7 B) was impaired only at
the highest concentration of ACh (10-4: 77 ± 11% vs. 37 ± 10%). These results suggest that
gestational whole-body nano-TiO2 exposure impairs normal umbilical physiological vascular
endothelial function. Additionally, this deleterious effect seems to be more pronounced in the
arterial circulation.

Endothelium-Independent Dilation
Endothelium-independent dilation of the umbilical artery was impaired in nano-TiO2 exposed
animals at 10-7 M (33 ± 14%) and 10-6 M (44 ± 14%) of SNAP compared to controls (53 ± 14%,
68 ± 14%) (Figure 8 A). In contrast to these findings, no point to point differences were seen in
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endothelium-independent dilation between control and nano-TiO2 exposed groups in the umbilical
(Figure 8 B).
Angiotensin II Sensitivity
Both umbilical vessels were treated with increasing concentrations of ANGII, a vasoactive agent
that has been strongly implicated in pre-eclampsia and gestational hypertension [17] . The
umbilical artery from nano-TiO2 exposed rats showed a remarkable increase in vasoconstriction
(-79 ± 20%) compared to controls (-36 ± 10%) (Figure 9 A). Interestingly, no differences were
seen in the response of the umbilical vein to ANGII between the Sham-control and nano-TiO2
exposed groups (Figure 9 B).

Placental Immunohistochemistry
Figure 10 A shows representative images of placental exposed sections stained with DAPI to
visualize the nuclei of the cells present in the placenta. Co-staining of vWF and SMA was
conducted to determine the localization of endothelial cells and to identify the blood vessels
forming the placental microvasculature. An enlarged (40x) image of a placental microvessel is
also shown (Figure 10 B). Immunohistochemistry of the placenta was conducted to: a) visualize
the microvascular architecture in support of the hypothesis that the observed changes in outflow
pressure may be ascribed to vasoactive responses, and b) verify the presence of the vascular
endothelium. Future studies using this co-staining technique will be used to determine the impact
of inhalation exposure on vascular density.
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Discussion
This is the first study to investigate the effects of gestational ENM inhalation exposure on placental
hemodynamics. Herein, we also present a novel microvascular adaptation to study placental
perfusion preparation [6]. The salient findings of the current work include that gestational nanoTiO2 exposure results in an increase in placental vascular resistance as evidenced by the
decrease in placental outflow pressure at baseline and following treatment with calcium-free
superfusate (Figure 3 A) and (Figure 5). Treatment of placentas with the endothelium-dependent
vasoactive agonist ACh increased average outflow pressure, indicating a decrease in vascular
resistance of the placenta (Figure 3 B) and (Figure 6). Perhaps the most interesting finding based
on our ex-vivo model is that placental and umbilical sensitivity to the vasoconstrictor ANGII is
significantly augmented by gestational nano-TiO2 exposure (Figure 3 D) and (Figure 7 C). While
the systemic microvascular effects of pulmonary ENM inhalation exposure have been previously
reported by our group [1,16,17] and others [27], the maternal-fetal vascular continuum remains
severely understudied. Impairments in endothelium-dependent dilation in the uterine
microcirculation [24] and umbilical vessels [28] caused by ENM exposure underscore the
importance of filling this knowledge gap.

The ability of ENM to not only cross the fetoplacental barrier and affect placental function, but
also to impair fetal development have previously been extensively reported [10]. Gestational
inhalation exposure to 230 µg/m3 of cadmium oxide nanoparticles resulted in a decrease in the
incidence of pregnancy by 23%, diminished placental weight and delayed neonatal growth [3].
Additionally, intragastric administration of hydroxyl-modified single-walled carbon nanotubes in
pregnant mice led to the development of skeletal defects, reduced ossification and morphological
abnormalities [21]. Pulmonary exposure to nanosilica with a primary diameter of 70 nm caused
significant fetal resorption and inhibited fetal growth [30]. Nano-TiO2 inhalation exposure has also
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been shown to be able to migrate to the uterus and induce fetal resorption and negatively affect
normal fetal development [19]. Furthermore, nano-TiO2 exposure is associated with a marked
reduction in placental weight, fetal weight and number and fetal dysplasia [9].

The fetoplacental vasculature governs nutrient, gas and waste exchange and its characteristic
low vascular resistance is essential for fetal health and conditions leading to an increase in
placental resistance have been associated with IUGR and preeclampsia [14]. Because the
placenta lacks autonomic innervation, vascular tone is dependent upon mechanical, autocrine,
circulating vasoactive factors and changes in smooth muscle tone in the villous resistance
vasculature. The umbilical artery and arterial tree is responsible for 57% of the total fetoplacental
resistance, while 17% is attributable to the capillary bed and 26% to the venous tree and umbilical
vein [22]. Therefore, any impairment in reactivity of the arterial and venous ends of the
fetoplacental vasculature will significantly affect placental resistance and ultimately compromise
developmental health.

Our results reflect that endothelium-dependent dilation in the maternal-fetal circulation is impaired
by maternal ENM inhalation exposure. NO plays a particularly crucial role in maintaining the low
basal tone of the maternofetal circulation, as reflected by NO synthase inhibitor infusion studies
that increase placental perfusion pressure. It is germane to indicate that such an NO dependency
most likely exists in the maternal microvascular circuit as NO signaling is not fully active in early
microvascular development. This phenomenon is also observable in the current study where ACh
treatment did not significantly increase placental outflow pressure vs the normal superfusate
response (Figure 3 A vs 3 B). Other pathways that may be involved include the potent vasoactive
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prostanoids, but previous experiments have shown that infusion of the cyclooxygenase inhibitor
indomethacin does not alter perfusion pressure of isolated placentas [14].
The renin-angiotensin system (RAS) is an important regulator of blood pressure as well as sodium
and fluid homeostasis. The placenta possesses an autonomous, local RAS which has been
associated with increased production of ANGII in IUGR and preeclampsia [23]. Within the
placenta, most of the effects of ANGII, such as vasoconstriction, angiogenesis and cell growth
are mediated by one of its cognate receptors, the AT1 receptor. Alternatively, the AT2 receptor
reduces endothelial proliferation, migration, apoptosis and stimulates vasodilation. An imbalance
between these two receptor populations in the maternal-fetal circulation resulting in an increased
expression of AT1 receptors has been observed in preeclamptic placentas [15] and may explain
the increase in sensitivity in nano-TiO2 exposed dams by both placentas and the umbilical artery
observed in this work. Future studies are therefore required to determine the involvement of the
maternal-fetal local RAS in the microvascular effects described herein.

There are several limitations to the ex-vivo perfused placental preparation adopted in this study
that must be considered. First, deterioration and breakdown of the placental tissue occurs very
rapidly once removed from the maternal environment. Therefore, this technique requires rapid
mounting of the placental units onto the pressure myography chambers in order to minimize the
deterioration of the tissue prior to and during experimentation. Second, measurements of the
outflow pressure were conducted blindly without real-time visualization of the changes in the
placental microcirculation. Lastly, the anatomical differences [8] between the human and rodent
placentas indicate that caution should be exercised when extrapolating the results of the current
study to humans. However, despite these differences, the vascular circuitry of the rodent placenta
remains very representative of the human maternal-fetal circulation. Future studies, aimed at realtime visualization of the placental microvasculature and determination of the effect of ENM
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exposure on anatomical outcomes such as vascular density and structure, will be necessary to
corroborate the present findings.

In conclusion, maternal ENM inhalation during gestation impairs fetoplacental vascular reactivity.
Additionally, it appears that anatomic changes may also accompany this dysfunction. Because
both may have profound impacts on fetal health, it is imperative to fully identify the underlying
mechanisms. We have initially identified endothelium-dependent and -independent effects herein,
as well as an increased sensitivity to ANGII. However, future studies further explore mechanisms
of reactivity such as pressure and shear-dependent vascular responses. Of equal importance is
to fully define the scope and depth of alterations in the fetoplacental vascular anatomy after
maternal ENM inhalation. Finally, the most sensitive periods during gestational development for
these toxicities should be determined.
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Figure Legends:
Figure 1. Characterization of Nano-TiO2. (A) SEM image of nano-TiO2, (B) Energy dispersive
spectroscopy showing elemental composition of the nano-TiO2 suspension used in this study, (C)
Nano-TiO2 size distribution (mobility diameter, 190 nm) using a scanning mobility particle sizer
(SMPS), (D) Nano-TiO2 size distribution (aerodynamic diameter, 188 nm) using a high resolution
electrical low-pressure impactor (ELPI). (E)

Total aerosol concentration (10 mg/m3) of

engineered nano-TiO2 during maternal exposures.

Figure 2. Ex vivo placental perfusion preparation. (A) Umbilical artery (1); vein (2). (B) Input
(arterial) perfusion pressure (1) (0-80 mm Hg) is held constant while vasoactive agonists are
added. Output pressure (2) and flow (3) (μl/min) are variables responsive to placental resistance.
Vascular diameter may be measured with video calipers. The chamber is designed for inverted
microscopy, and fluorescent biomarkers may be easily added to the perfusate or superfusate.

Figure 3. Maternal nano-TiO2 inhalation exposure impairs endothelium-dependent
placental hemodynamics. Mean outflow pressures were measured in sham-control and nanoTiO2 exposed animals after the inflow pressure was increased in a stepwise manner and set at 0
mm Hg, 20 mm Hg, 40 mm Hg, 60 mm Hg and 80 mm Hg. Nano-TiO2 inhalation exposure altered
placental hemodynamics and decreased outflow (venous) pressure in placentas in normal
superfusate (A) and placentas treated with ACh (B) (n=8). *, P ≤ 0.05 sham-control group vs.
nano-TiO2 exposed group.

Figure 4. Maternal nano-TiO2 inhalation exposure does not affect endotheliumindependent placental hemodynamics but increases ANGII sensitivity. Mean outflow
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pressures were measured in sham-control and nano-TiO2 exposed animals after the inflow
pressure was increased in a stepwise manner and set at 0 mm Hg, 20 mm Hg, 40 mm Hg, 60
mm Hg and 80 mm Hg. Maternal nano-TiO2 inhalation exposure did not affect endothelialindependent placental hemodynamics (A) but increased ANGII sensitivity (B) (n=8). *, P ≤ 0.05
sham-control group vs. nano-TiO2 exposed group.

Figure 6. Nano-TiO2 inhalation exposure and placental mean outflow pressure. Mean
outflow pressure at 80 mm Hg inflow pressure in both Sham-control and nano-TiO2 exposed
groups and all treatment conditions is shown (n=8). Statistics were analyzed with a student`s ttest (P ≤ 0.05), * Sham control group vs. nano-TiO2 exposed groups.

Figure 7. Maternal nano-TiO2 inhalation exposure impairs endothelium-dependent dilation
of the umbilical artery and vein. (A) Endothelium-dependent dilation of the umbilical artery, (B)
endothelium-dependent dilation of the umbilical vein from Sham-control and nano-TiO2 exposed
animals was determined using pressure myography (n=12-14). Statistics were analyzed with twoway ANOVA (P ≤ 0.05). * Sham control group vs. nano-TiO2 exposed group.

Figure 8. Maternal nano-TiO2 inhalation exposure impairs endothelium-independent
dilation of the umbilical artery and vein. (A) Endothelium-independent dilation of the umbilical
artery, (B) endothelium-independent dilation of the umbilical vein from Sham-control and nanoTiO2 exposed animals was determined using pressure myography (n=12-14). Statistics were
analyzed with two-way ANOVA (P ≤ 0.05). * Sham control group vs. nano-TiO2 exposed group.

Figure 9. Maternal nano-TiO2 inhalation exposure increases ANGII sensitivity of the
umbilical artery. (A) ANGII dose-response curve of the umbilical artery (A) and vein (B) from
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Sham-control and nano-TiO2 exposed animals was determined using pressure myography (n=1214). Statistics were analyzed with two-way ANOVA (P ≤ 0.05). * Sham control group vs. nanoTiO2 exposed group.

Figure 10. Placental immunohistochemistry. Smooth muscle actin is green, Von-Willebrand
Factor is red, and DAPI nuclear staining is blue. (A) Representative image showing
immunohistochemistry of a placental section from maternal nano-TiO2 exposed animal. The
purpose was to identify the microvascular architecture and the structural components of the
placenta. (B) An enlarged (40x) image of a placental microvessel displaying an intact endothelium
(green).
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V. General Discussion
The primary objective of this dissertation project was to determine the effects of acute pulmonary
ENM exposure on the microcirculation and identify the potential mechanisms resulting in vascular
dysfunction. Overall, this dissertation project can be divided into 3 distinct components. The first
part maps the effects of ENM exposure on vascular reactivity along the vascular tree (i.e. from
the macrocirculation to the microcirculation) and identifies the most sensitive segments to
pulmonary ENM insult by assessing endothelium-dependent, endothelium-independent and
adrenergic responsiveness. The second study identifies the involvement of innate lymphoid cells
in the acute inflammatory response to nano-TiO2. Lastly, the third and final component of this
work assess the effect of maternal gestational inhalation exposure to nano-TiO2 on placental
vascular resistance and umbilical vascular reactivity.

A) Vascular Heterogeneity and Microvascular Sensitivity
The microcirculation is crucial for the generation of the total peripheral resistance necessary for
adequate tissue perfusion and nutrient-waste exchange and unresolved impairments in its
function may contribute to the development of several systemic conditions such as diabetes and
hypertension [46]. Notwithstanding the prominent role played by the microvasculature in the tissue
perfusion, the mechanisms through which ENM inhalation exposure disrupts normal vascular
function remain to be clarified. In general, all the studies indicated that pulmonary ENM exposure
causes endothelium-dependent dysfunction in the microvasculature.

Study 1 first identified and directly compared the differential effect of ENM exposure on discrete
anatomical segments of the vascular tree in different vascular beds. Acute pulmonary ENM
exposure was associated with microvascular and macrovascular dysfunction caused by an
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impairment in endothelium-dependent and endothelium-independent dilation. Lastly, the
dysfunction observed at the microvascular level was the most robust, underscoring the sensitivity
of the microcirculation to acute pulmonary ENM exposure. In this series of experiments, nanoTiO2 exposure was found to significantly decrease endothelium-dependent relaxation in the
thoracic aorta, the femoral arteries and third-order mesenteric arterioles. Furthermore, what is
undoubtedly most compelling is the finding that exposure to high concentrations of nano-TiO2
almost completely abolished endothelium-dependent dilation and acetylcholine sensitivity in 4th
and 5th order mesenteric arterioles. It is also worth noting that a dose-independent effect of nanoTiO2 was seen on the reactivity of the thoracic aorta. Indeed, the lowest dose of nano-TiO2 (20
µg) induced the greatest endothelium-dependent dysfunction, while the intermediate dose (100
µg) caused the most robust decrease in endothelium-independent responsiveness. Additionally,
nano-TiO2 exposure significantly decreased the mean inner diameter and the tone of the 4th and
5th mesenteric arterioles. Studies 2 and 3 confirmed the systemic vascular effects of nano-TiO2,
indicating that the observed impairments were independent of the vascular bed and exposure
technique used (whole-body inhalation vs. instillation).

Impairments in the endothelium-dependent dilation following ENM exposure have been
extensively reviewed [1]. Indeed, microvascular function has been shown to be impaired in the
coronary [30], uterine [51], mesentery [36], and pulmonary [11] microvasculature following
particulate matter exposure.

The endothelial layer is composed of receptor-effector cells capable of sensing different physical
or chemical intravascular stimuli. These cells then produce a large array of paracrine, endocrine
and autocrine agonists that counteract the effect of these stimuli and maintain homeostasis. Nitric
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oxide (NO) is perhaps the most ubiquitous and most studied vasodilator produced by endothelial
cells. NO is a biologically active, lipophilic gas capable of diffusing easily across membranes and
of crossing the endothelial intima and reaching the vascular smooth muscle tissue, subsequently
stimulating the degradation of guanosine triphosphate (GTP) to release cyclic guanosine
monophosphate cGMP, which in turn is responsible for vascular smooth muscle relaxation and
vasodilation [6].

NO is produced by the enzymatic action of nitric oxide synthase (NOS) on the amino acid Larginine, which results in the production of NO and L-citrulline. For this transamination reaction
to occur, O2 and the coenzyme nicotinamide adenine dinucleotide phosphate must be present.
Cofactors such as tetrahydrobiopterine (BH4) and flavine-adenine dinucleotide (FAD) [6].
Endogenous vascular NO production is severely compromised after ENM exposure [39] as a
result of oxidative stress, inflammation and/or direct particle interaction with the tissues. Oxidant
products such as the superoxide anion, hydrogen peroxide, the hydroxyl radical, hypochlorous
acid and lipid radicals are normally produced during aerobic metabolism. The resulting molecules
are extremely reactive and are known as Reactive Oxygen species (ROS). Under normal
conditions, ROS generation is controlled by the presence of antioxidants and enzymes including
superoxide dismutase, glutathione peroxidase and catalase which are responsible for the
conversion of ROS to oxygen and water. Following ENM exposure, the intracellular levels of ROS
have been shown to drastically increase resulting in oxidative stress [36]. Excess of ROS may
lead to the oxidation of NO leading to the formation of peroxynitrite (ONOO), an extremely reactive
molecule that can result in more oxidation. In this way, intravascular NO concentrations may
significantly decrease, thus affecting their vasodilatory responses.
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The most important stimulus for the basal release of NO by endothelial cells is shear stress [29].
The hemodynamic conditions within the vasculature lead to the development of superficial stress
on the vessel walls due to blood flow which is applied mainly to the endothelial layer. Increases
in blood flow velocity lead to an increase in shear stress and a vasodilation proportional to the
amount of NO released by the endothelium [42,43]. This NO mediated response, otherwise known
as endothelium-dependent dilation, is mediated by specialized ion channels, such as Ca2+activated K+ channels, that open in response to changes in shear stress [42], causing
hyperpolarization of the endothelial cells, the influx of Ca2+ and the generation of NO [6].

The observed endothelium-dependent dysfunction may have also been induced by the local
deposition of hemoproteins [13]. Myeloperoxidase, a microbicidal molecule secreted by
leukocytes, has been shown to deposit around vascular endothelial cells in response to ENM
exposure [38], resulting in an impaired endothelium-dependent response. Altered vascular
responsiveness has been associated with catalytic consumption of NO by the substrate radicals
generated (hypochlorous acid). Decreased NO generation and microvascular dysfunction have
also been observed following MWCNT exposure and linked to the activation of the scavenger
receptor CD47 [33]. CD47 signaling is activated by thrombospondin-1 (TSP-1), a primary
component of the α-granules of platelets [34, causing activation of NADPH oxidase-1 (NOX-1) in
endothelial cells and leukocytes [45]. Activation of NOX-1 results in ROS generation and
subsequent leukocyte adhesion, endothelial disorganization and permeability [12], which may
further promote endothelial dysfunction.

The decreased endothelium-independent dilation observed in study 1 may have been caused by
alterations in VSM signaling. ENM exposure may result in changes in calcium handling or an

177

increase in phosphodiesterase activity - both of which may reduce the sensitivity to the
vasodilatory effect of NO [11]. Changes in vascular contractility may also occur due to alterations
in RhoA signaling [52]. The RhoA-Rho kinase pathway may contribute to an increase in the
contractile response in VSM via regulation of intracellular calcium and phosphorylation of myosin
light chain phosphatase [17]. Indeed, an increase in Rho-kinase activity has been shown to be
associated with increased responsiveness to PE and endothelin-1 in uterine and aortic segments
following intravenous exposure to fullerenes [52]. Furthermore, up-regulation of the Rho-kinase
pathway has also been linked to decreased expression and activity of eNOS [13], which may
reduce relaxation and enhance vascular contraction.

B) Potential Mechanisms

Historically, epidemiological studies have extensively confirmed a causal relationship between
particulate matter exposure and cardiovascular morbidity and mortality [44], and 3 generalized
intermediary biological pathways and specific biological responses have been implicated; direct
tissue-particle interaction, systemic oxidative stress and inflammation and dysregulation of the
autonomic nervous system [44].

The inflammatory hypothesis, which states that pulmonary ENM exposure to particulate matter
initiates a systemic inflammatory response, is undoubtedly the most studied. The immune
response to ENM exposure involves both the innate and adaptive branches [7]. Within the
literature (for example [7]), studies have shown that the innate immune system plays a central
role in the host response against inhaled particles and fibers [10]. Most inhaled ENM deposited
in the alveolar regions are phagocytized by alveolar macrophages [7]. Individual ENM may,

178

however, escape phagocytosis and interact directly with pulmonary epithelial cells [4]. ENM taken
up by macrophages are cleared from the lungs via the mucociliary escalator and the lymphatic
system [7]. High aspect ratio ENM (CNT, nanofibers, nanowires), nano-TiO2, or the formation of
bridges by CNT bundles may disrupt macrophage clearance, leading to cytokine secretion [55].
CeO2-NP have been reported to impair peripheral monocyte function by inducing mitochondrial
damage and overexpression of the apoptosis-inducing factor, leading to increased autophagy [8].
High-aspect ratio ENM activate the inflammasome in alveolar macrophages and trigger the
secretion, via disruption of lysosomal integrity and ROS, of the proinflammatory cytokines IL-1β
and IL-18 [34]. Ag-NP [22] and MWCNT [23] increase the expression of NF-κB and
cyclooxygenase-2 (COX-2) in RAW264.7 macrophages in vitro. These inflammatory mediators
may trigger a systemic inflammatory cascade by activating other immune effector cells including
innate lymphoid cells.

The most conspicuous knowledge gap is the one linking these immune effects with the systemic
microvascular dysfunction. For this reason, the main objective of study 2 was to study the potential
mechanism linking acute pulmonary ENM exposure and the observed microvascular
impairments. The salient findings of study 2 are that acute pulmonary nano-TiO2 causes epithelial
cell injury, as evidenced by the increased pulmonary levels of the epithelial “alarmin” IL-33.
Additionally, nano-TiO2 instillation increased BALF and circulating levels of the TH2 cytokines IL4, IL-5 and IL-13 after only 2 hours. The impairment in endothelial-dependent dilation observed
in the uterine microcirculation was partially improved by pre-treatment with an antibody specific
for IL-33. The finding that ENM exposure increases lung IL-33 levels has been previously reported
in other studies with MWCNT [5]. It is known that canonically-activated naive Th2 cells require
prolonged continuous stimulation by antigen-presenting cells [2]. Therefore, we investigated the
potential role of innate lymphoid cells (ILC1 and ILC2), which have been already implicated in
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asthmatic responses to environmental allergens [56] and acute lung injury [35]. Interestingly,
nano-TiO2 increased ILC2 but not ILC1 levels within the lungs as early as 4 hours post-exposure.
These results point to the shifting of the innate immune response to ENM towards a non-canonical
Th2 or allergic phenotype [56]. Moreover, ILC2 are the dominant population of innate lymphoid
effector cells in the lungs and are capable of secreting large amounts of TH2 cytokines in response
to specific stimuli [2]. In mice, an IL-25 inducible, lineage negative cell population was shown to
secrete large amounts of IL-5 and IL-13 [56]. In humans, a CD34+ cell population expressing the
receptor for IL-33 (IL-33R) was identified and shown to secrete Th2 cytokines upon treatment with
IL-33 [56]. The location of ILC2 at barrier sites and mucosal tissue [2] is especially important,
especially in the lung where they have been associated with airway hyper-reactivity on exposure
to house dust mites [56] and papain [32]. Interestingly, airway hyper-reactivity and increased
airway resistance have also been reported following ENM inhalation exposure [5]. In mice,
MWCNT exacerbate allergic airway inflammation following ovalbumin sensitization [5].

ENM inhalation may lead to the release within the lungs of alarm signals or damage associated
molecular patterns (DAMPs) such as IL-33 directly into the lung microenvironment and into the
circulation. These DAMPs may then acutely stimulate both the proliferation of lung-resident ILC2
and the migration of circulating ILC2 to the lungs. Once stimulated, ILC2 secrete significant
quantities of the cytokines IL-4, IL-5 and IL-13. IL-5 has been shown to be necessary for
eosinophil homeostasis and B cell function [2]. In addition, induction of B cell proliferation and
secretion of IgA, IgM, IgE and IgG1 have also been shown in vitro and in vivo [2]. Further, IL-4
and IL-13 have the potential of targeting non-immune and immune cells present in the lungs.
These mediators initiate mucus secretion, goblet hyperplasia, priming of macrophages, dendritic
cells and neutrophils [48]. Therefore, ENM likely trigger the release of soluble cytokines from the
lungs since evidence of translocation from the lung is scarce [40]. Nonetheless, it is possible that
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a small proportion of the inhaled ENM will translocate from the lung to distant organs and tissues
and impair their function by directly disrupting tissue barriers [34], catalyzing Fenton-reactions
and potentially inducing local oxidative stress.

The proinflammatory cytokines and chemokines secreted into the circulation may then activate
circulating neutrophils and vascular endothelial cells [16]. Studies by our group have identified
acute increases in neutrophil rolling and adhesion following inhalation exposure to nano-TiO2 in
uterine venules [51] and to CeO2-NP in the mesenteric microcirculation [36]. Therefore, it is likely
that pulmonary ENM exposure promotes leukocyte tethering, rolling and adhesion. Further
studies are needed to confirm the role of ILC2 in the acute response to pulmonary ENM exposure
and the link between Th2 mediators and leukocyte/endothelium activation.

The inflammatory and direct-tissue interaction hypotheses cannot entirely account for the vascular
dysfunction associated with pulmonary ENM exposure. Indeed, increasing evidence suggests
that PM (including ENM) may interact with the central nervous system and/or stimulate an
autonomic arc between the lung and the systemic tissue [49]. For example, ultrafine particulate
matter has been shown to induce a pulmonary inflammatory response resulting in histamine
release from unmyelinated C fibers and mast cells [37]. Stimulation of these vagal afferent
neurons may lead to dysregulation of autonomic signaling. Furthermore, intratracheal instillation
of 1 mg/ml of SWCNT altered baroreflex function in Wistar-Kyoto rats, thus affecting the
autonomic control of cardiovascular function [27]. Potential central pathways that may be affected
by ENM exposure include the jugular and nodose ganglia, which receive feedback from
pulmonary C-fibers and project to the cardiovascular center present in the medulla oblongata.
Recently, pulmonary exposure to nano-TiO2 was shown to significantly increase heart rate and
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decrease diastolic function in rats treated with isoproterenol, a non-selective β adrenoreceptor
agonist, while elevating mean and diastolic pressure in response to norepinephrine [27].
Additionally, inhalation of MWCNT for 5 hours at a concentration of 5 mg/m3 altered the balance
between sympathetic and parasympathetic inputs determined by changes in heart rate variability.
An increase in sympathetic tone and decreased cardiac parasympathetic vagal tone may
therefore be in part responsible for the cardiovascular effects observed post-exposure to ENM.
ENM may also bypass the BBB by anterograde neuronal transport via the olfactory bulb [19].
Indeed, manganese oxide and nano-TiO2 have been shown to reach the striatum, frontal cortex,
thalamus, hippocampus, cerebellum, and brain stem [15]. However, confirmation of autonomic
dysfunction via this pathway requires further investigation.

3) Developmental Origin of Health and Diseases

This last section will address the effect of gestational ENM exposure on the vascular resistance
of the maternal-fetal circulation\. In study 1 we identified the pronounced sensitivity of the
microcirculation to ENM exposure while in study 2 we proposed a novel potential immune link
between the pulmonary route of exposure and the microvasculature. The aim of study 3 was to
determine the effects of ENM exposure on the maternal-fetal circulation, particularly on the
umbilical macrocirculation and on the placental microcirculation. Inhalation nano-TiO2 exposure
decreased endothelium-dependent dilation in the umbilical artery while increasing ANGII
sensitivity. Further, gestational ENM exposure decreased mean placental outflow pressure in
response to ACh, ANGII and Ca2+-free superfusate.

Overall, vascular resistance in the maternal-fetal circulation is increased by gestational ENM
exposure. As mentioned above, the flow rate within a vessel is dependent upon the pressure
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differential within a vessel and the vascular resistance. Increases in resistance, due to an increase
in vessel length, a decrease in vessel density or diameter will have the greatest impact on the
ability of the placenta to adequately perfuse the developing fetus. Indeed, studies with AgNP (1820 nm) confirm the ability of ENM to translocate to the placenta and induce fetal resorption [25].
Nano-TiO2 has been shown to accumulate in the placenta and translocate to the developing fetus
[24]. Gavage of 1 mg/kg/day nano-TiO2 also reduced the ratio of placenta/body weight by GD 13
in mice [41]. In the same study, impaired vascularization and fetal microvascular network
development were noted.

The effects on placental structure and function have been attributed to an interplay between
several mechanisms. AgNP have been shown to increase the proinflammatory cytokines IL-6, IL1β, TNFα and MCP1 in the lungs of pregnant mice. Placental TNFα, which plays a role in placental
inflammation, and IL-1β secreted by infiltrating macrophages are also upregulated [22]. Inhibition
of trophoblast proliferation and increased apoptosis by nuclear pyknosis through upregulation of
caspase 3 and Bax and downregulation of Bcl-2 have been shown to occur in mice in response
to nano-TiO2 exposure [56]. Nano-TiO2 also increases ROS levels in both the uterus and the
placenta [56], causing a subsequent decrease in NO bioavailability, a mechanism which may in
part account for the decreased sensitivity to ACh seen in study 3.

Study 3 indicated an increase in sensitivity to ANGII in umbilical vessels and placentas from nanoTiO2 inhalation exposed animals. We investigated the influence of ENM exposure on the placental
RAS response. AgNP and nano-TiO2 have been shown to cause an imbalance in the local brain
RAS system via increased ROS levels and inflammation [54], resulting in increased levels of
angiotensin converting enzyme and ANGII. Therefore, a similar effect may have occurred in the
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maternal-fetal vasculature and may explain the observations reported in study 3. ENM exposure
may lead to an imbalance in the ANGII receptor populations in the maternal-fetal circulation
resulting in the increased expression and availability of AT1 receptor. ANGII acting via the AT1
receptor activates NADPH oxidase and causes impaired endothelial function and flow-mediated
vasodilation, inflammation, atherosclerosis, vascular hypertrophy and inward remodeling during
pathology [47]. These phenomena result in reduced maternal-fetal blood flow and may have
significant effects on fetal development. Indeed, increases in ANGII levels during gestation have
been linked to decreased fetal size and preeclampsia [28].

Vasomotor tone is influenced by ANGII via activation of the AT1 receptors. ANGII binding of the
AT1 receptor activates phospholipase C, leading to the formation of the secondary messengers
inositol-1-4-5-trisphosphate and diacylglycerol, which subsequently results in an increase in
intracellular calcium levels and phosphorylation of myosin light chain and stimulation of sustained
contraction [20]. Furthermore, ANGII may affect VSM contraction via the RhoA/Rho kinase
pathway, leading to an increased sensitivity to intracellular concentrations of free calcium due to
the inhibition of myosin light chain phosphatase [21]. Additionally, ANGII also increases the
formation of NOX and arachidonic acid–derived ROS, thus stimulating the contraction of VSM
[45]. ANGII has been shown to primarily target VSM but may also regulate endothelial transient
receptor channels by influencing calcium-activated potassium which are involved in vascular
contraction and relaxation [9]. Therefore, the observed effects of gestational nano-TiO2 exposure
on maternal-fetal vascular resistance may involve an increase in sensitivity to ANGII as a result
of an increase in AT1 receptor population which may lead to an increase in vascular tone.
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4) Conclusions and Future Directions
It is clear that the systemic and microvascular effects associated with pulmonary nano-TiO2 are
extensive and involve several mechanisms, some of which have yet to be uncovered. Therefore,
it was the objective of this dissertation work to propose ILC2 as potential innate immune effector
cells associated with pulmonary ENM exposure and identify an understudied yet important target
of ENM exposure (the placenta). There is extensive evidence indicating that nano-TiO2 impairs
cardiovascular function in healthy male animal models but its effects on susceptible populations
such as pregnant women and developing fetuses are unknown. The differential effects observed
in pregnant and virgin animal models and the significant impact on fetal development, mandate
more thorough investigations of the reproductive and developmental consequences of ENM.

Defining the physico-chemical properties (size, shape, surface charge, functionalization etc.) and
the critical window for gestational exposure will also be important for the determination of the
effects of ENM on fetal health. Unfortunately, studies 2 and 3 assessed the effect of a single dose
and a single type of ENM. All of the experiments in study 3 were conducted on GD 20, while the
exposures were initiated on GD 11, well after implantation. Future studies should focus on
identifying the impact of different ENMs at different times prior to and during gestation and
clarifying the link between physico-chemical properties and reproductive toxicity.

Research on the reproductive effects of ENM in general is still in its infancy and many intriguing
questions remain unanswered. The studies in this dissertation work will be a stepping-stone for
future work aimed at clarifying the acute inflammatory mechanisms and the role played by the
placenta in ENM exposure.
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VI. Appendices
Appendix A:
Supplementary Figure 1. IL-33 sequence homology. Multiple sequence alignment of the protein
sequence of IL-33 in mice (query) and rats (subject) showing the significant interspecies
homology of murine IL-33.
Appendix B:
Supplementary Figure 1. Maternal nano-TiO2 inhalation exposure impairs endotheliumdependent placental hemodynamics. Regression analysis showing that maternal nano-TiO2
inhalation exposure alters placental hemodynamics and decreases outflow (venous) pressure in
placentas in normal superfusate (A) and placentas treated with ACh (B) (n=8). *, P ≤ 0.05 shamcontrol group vs. nano-TiO2 exposed group.
Supplementary Figure 2. Maternal nano-TiO2 inhalation exposure does not affect
endothelium-independent placental hemodynamics but increases ANGII sensitivity.
Regression analysis showing that maternal nano-TiO2 inhalation exposure did not affect
endothelial-independent placental hemodynamics (A) but increased ANGII sensitivity (B) (n=8).
*, P ≤ 0.05 sham-control group vs. nano-TiO2 exposed group.
Supplementary Figure 3. Maternal nano-TiO2 inhalation impairs calcium-free placental
hemodynamics. Regression analysis showing that maternal nano-TiO2 inhalation exposure
alters placental hemodynamics and decreases outflow (venous) pressure in placentas in calciumfree superfusate (n=8). *, P ≤ 0.05 sham-control group vs. nano-TiO2 exposed group.

193

Appendix A
Supplementary Figure 1:

194

Appendix B
Supplementary Figure 1:

195

Supplementary Figure 2:

196

Supplementary Figure 4:

197

VII. Curriculum Vitae
Alaeddin Bashir Abukabda
Physiology and Pharmacology Department
Robert C. Byrd Health Sciences Center
64 Medical Center Drive West Virginia University
Morgantown, WV 26506-9105

Email: ababukabda@mix.wvu.edu

Education
Al Fateh University (2002-2006)
Department: Dentistry
Major: Dentistry
Degree Conferred: D.M.D

Clarion University of Pennsylvania (2008-2011)
School: Arts & Sciences Department: Biology
Concentration:

Molecular

Biology

Degree

Conferred: M.Sc.
West Virginia University (2014-2018)
School: Medicine
Division: Cellular and Integrative Physiology
Degree: PhD

West Virginia University (2016-2018)
School: Public Health
Division: Epidemiology and Biostatistics
Degree: Certification in Biostatistics

198

History
2009-2011 - Clarion University of PA - Laboratory Assistant for Anatomy and Physiology
Laboratory Assistant for Introduction to Biology

2009-2011 - Clarion University of PA - Graduate Assistant,
Molecular Biology, Master’s Candidate
Department of Biology Advisor: Douglas Smith

2009-2011 – Clarion Research Group - Researcher

2014-2018 - West Virginia University - Graduate Research Assistant, Department of
Physiology and Pharmacology Advisor: Timothy R. Nurkiewicz, Ph. D

Previous Teaching Experience
Biology I and II lab and lecture – 2009-2011
Practice Based Learning Class - 2018
Cell Methods - 2016-2017

Awards/Achievements
o

Van Liere Research Day Award – 2018

o

Maryanne Stock Research Award – 2018

o

Cardiovascular Toxicology Specialty Section Student Award – 2018

o

Reproductive Toxicology Specialty Section Student Award - 2018

o

Julie Betschart Award - 2017

o

American Public Health Association Award – 2017

o

FASEB MARC Travel Award – 2017

o

Society of Teratology Travel Award – 2017

o

Society of Toxicology Travel Award – 2017

o

International Nanotoxicology Congress Travel Award - 2016

199

o

Joint Regional American Association of Pharmaceutical Scientists (AAPS) 2015 and
International Society for Pharmcoeconomics and Outcomes Research (ISPOR), Morgantown
WV

o

Clarion University Outstanding Graduate Student Award - 2011

o

Clarion University Research Award - 2010

o

Dean’s List 2008-2011

o

NESA Ugrad - Fulbright Scholarship 2008

o

Robert Moore Award for Academic Excellence 1998-2000

Positions
o Member, Center for Cardiovascular and Respiratory Sciences 2015-present
o Member, The Microcirculation Society 2015-present
o Member, Society of Toxicology 2015-present
o Member, Alleghany-Erie Regional Chapter SOT 2015-present
o Member, National Society for Leadership and Success 2009-2011

Invited Symposia
o WVU, Department of Physiology and Pharmacology, Morgantown,
WV. (2015): “Nano-Titanium Dioxide Differentially Impairs Segmental Vascular Reactivity and
Endothelial Cell Function”. o Research and Education in Nanotoxicology at West Virginia
Interdisciplinary Graduate Education and Research Traineeship and NanotechnologyEnvironmental Effects and Policy (REN@WVU- NEEP) Collaborative Symposium. (2015):
“Exposure to Nano-titanium Dioxide Differentially Impacts Vascular Cholenergic Sensitivity.”
o WVU, Department of Physiology and Pharmacology, Morgantown, WV. (2014): “Effects of Acute
Exposure to Nanomaterials on Macrovascular Reactivity”.

200

Publications
Peer Reviewed Manuscripts
1.

Abukabda, A.B., et al., Group II innate lymphoid cells and microvascular dysfunction from

pulmonary titanium dioxide nanoparticle exposure. Part Fibre Toxicol, 2018. 15(1): p. 43.
2.

Stapleton, P.A., et al., Estrous cycle-dependent modulation of in vivo microvascular

dysfunction after nanomaterial inhalation. Reprod Toxicol, 2018. 78: p. 20-28.
3.

Stapleton, P.A., et al., Maternal engineered nanomaterial inhalation during gestation alters

the fetal transcriptome. Part Fibre Toxicol, 2018. 15(1): p. 3.
4.

Nichols, C.E., et al., Reactive oxygen species damage drives cardiac and mitochondrial

dysfunction following acute nano-titanium dioxide inhalation exposure. Nanotoxicology, 2018.
12(1): p. 32-48.
5.

Stefaniak, A.B., et al., Inhalation exposure to three-dimensional printer emissions

stimulates acute hypertension and microvascular dysfunction. Toxicol Appl Pharmacol, 2017.
335: p. 1-5.
6.

Abukabda, A.B., et al., Heterogeneous Vascular Bed Responses to Pulmonary Titanium

Dioxide Nanoparticle Exposure. Front Cardiovasc Med, 2017. 4: p. 33.
7.

Hathaway, Q.A., et al., Maternal-engineered nanomaterial exposure disrupts progeny

cardiac function and bioenergetics. Am J Physiol Heart Circ Physiol, 2017. 312(3): p. H446-H458.
8.

Abukabda, A.B., P.A. Stapleton, and T.R. Nurkiewicz, Metal Nanomaterial Toxicity

Variations Within the Vascular System. Curr Environ Health Rep, 2016. 3(4): p. 379-391.
9.

Stapleton, P.A., et al., Xenobiotic pulmonary exposure and systemic cardiovascular

response via neurological links. Am J Physiol Heart Circ Physiol, 2015. 309(10): p. H1609-20.
10.

Davis, V.L., et al., Platelet-rich preparations to improve healing. Part II: platelet activation

and enrichment, leukocyte inclusion, and other selection criteria. J Oral Implantol, 2014. 40(4): p.
511-21.

201

11.

Davis, V.L., et al., Platelet-rich preparations to improve healing. Part I: workable options

for every size practice. J Oral Implantol, 2014. 40(4): p. 500-10.

Book Chapter
1. Stapleton PA, Abukabda AB, Nurkiewicz TR. “Assessment of Vascular Reactivity” in:
Cardiovascular Toxicology, of Cardiovascular Physiology 3rd edition (in preparation)
2. Stapleton PA, Abukabda AB, Nurkiewicz TR. “Principles of Toxicology” in: Modern
Pharmacology, (in review)
3. “Complications of Oral Implantology” – Quintessence Publishing, 2011

Abstracts
1. Abukabda AB, Stapleton PA, McBride CR, Yi J, Nurkiewicz TR. Heterogeneity of the Vascular
Response to Acute Pulmonary Nano-TiO2 Exposure. The Toxicologist (2017)
2. Nichols CE, Hollander JM, Engels K, Abukabda AB, Stapleton PA, Nurkiewicz TR. Maternal
Nanomaterial Inhalation During Gestation Impairs Microvascular Reactivity and Alters the Fetal
Genome. The Toxicologist (2016)
3. Abukabda AB, Stapleton PA, Nurkiewicz. Nano-Titanium Dioxide Exposure Differentially
Affects Segmental Vascular Reactivity. The Toxicologist (2016)
4. Abukabda AB, Stapleton PA, Nurkiewicz. Exposure to Nano- titanium Dioxide Differentially
Impacts Vascular Cholenergic Sensitivity. Research and Education in Nanotoxicology at West
Virginia Interdisciplinary Graduate Education and Research Traineeship and NanotechnologyEnvironmental Effects and Policy (REN@WVU-NEEP) Collaborative Symposium. (2015)

202

5. Simon SA, Stapleton PA, Abukabda AB, McBride CR, Nurkiewicz, TR. Engineered
Nanomaterial Effects on the Cardiovascular Effects. West Virginia IDeA Network of Biomedical
Research Excellence (WV- INBRE), Huntington, WV (2015)
6. Krupa RC, Stapleton PA, Abukabda AB, Minarchick VC, Nurkiewicz, TR. Impact of
nanomaterial Exposure on the Reactivity of Small Arteries in the Mesentery. WVNano Research
Experiences for Undergraduate, Summer Undergraduate Research Symposium, Morgantown,
WV (2015)
7. Abukabda AB, Stapleton PA, Nurkiewicz, TR. Acute Exposure to Nano-Titanium Dioxide
Differentially Impairs Endothelial Cellular Signaling. Joint Regional American Association of
Pharmaceutical Scientists (AAPS) and International Society for Pharmcoeconomics and
Outcomes Research (ISPOR), Morgantown WV (2015)
8. Abukabda AB, Stapleton PA, Nurkiewicz, TR. Differential Effects of Nano-Titanium Dioxide
Exposure on Vascular Reactivity. Alleghany-Erie Society of Toxicology (2015)
9. Abukabda AB, Stapleton PA, Nurkiewicz, TR. Dose-Dependent Effect of Nano-Titanium
Dioxide Exposure on Aortic Reactivity. West Virginia University, Van Liere Research Day (2015).

Student Mentorship and Supervision
o Julie Griffith - Fall 2018
o Krista Garner – Fall 2017
o Elizabeth Bowdridge - Fall 2017
o Wijdan Dabeek, Research Experience - Fall 2016 – 2017
o Spencer Duffey, Pharmacy Student, Research Internship - Fall 2014 - present

203

o Andrew Nickerson, Graduate Research Rotation - Fall 2015
o Samantha Simon, WVU INBRE and Health Science Technology Academy (HSTA) Program,
University High School, Morgantown WV - Summer 2015
o Rebekah Krupa, Research Experience for Undergraduates, WVU NanoSAFE - Summer 2015
Professional Journal Activities
Ad Hoc Reviewer
o American Journal of Physiology- Lung, Cellular and Molecular Physiology o Environmental
Health Perspectives
o Cardiovascular Toxicology
o Chemosphere
o Inhalation Toxicology
o Journal of Nanomedicine and Nanotechnology
o Journal of Toxicology and Environmental Health o Journal of Visualized Experiments
o Life Sciences
o Medicine and Science in Sports and Exercise o Molecules
o Microcirculation o Nanomedicine
o Nanotoxicology
o Nigerian Medical Journal
o Particle and Fibre Toxicology
o PLoS ONE

204

o Reproductive Toxicology
o Toxicology and Applied Pharmacology
o WIREs Nanomedicine and Nanobiotechnology o Toxicological Sciences
o Journal of Toxicology and Applied Pharmacology

Memberships (Past and Current)
o The Microcirculation Society
o The Center for Cardiovascular and Respiratory Sciences
o Society of Toxicology
- Cardiovascular Toxicology Specialty Section
- Nanotoxicology Specialty Section
- Immunotoxicology Specialty Section
- Inhalation Toxicology Specialty Section
- Toxicologists of African Origin
- Allegheny-Erie Regional Chapter
- The Teratology Society – Education Committee and Awards Committee
-American Public Health Association

205

Participation in Scientific Meetings
o International Nanotoxicology Congress (2016, 2018)
o Society of Toxicology National Meeting (2016-2018).
o Allegheny-Erie Regional Chapter of the Society of Toxicology Annual Meeting (2015-2018).
o The Teratology Society National Meeting (2017)
o American Public Health Association Annual Meeting (2017)

Continuing Education Symposia/Webinar
o Betschart Symposium, West Virginia University (2016, 2017)
o Grant Writers’ Seminar and Workshop (2015)
o Research and Education in Nanotoxicology at West Virginia Interdisciplinary Graduate
Education and Research Traineeship and Nanotechnology-Environmental Effects and Policy
(REN@WVU- NEEP) Collaborative Symposium. (2015)
o Joint Regional American Association of Pharmaceutical Scientists (AAPS) and International
Society for Pharmcoeconomics and Outcomes Research (ISPOR), Morgantown WV (2015, 2018)
o Van Liere Research Day, West Virginia University (2015-2018).

206

